Influence of Supplemental Vitamin E and Zinc on the Response of Mouse Macrophages to Lipopolysaccharide by Bell, Mary Rachel
THE INFLUENCE OF SUPPLEMENTAL 
 
VITAMIN E AND ZINC ON THE 
 










MARY RACHEL BELL 
 
Bachelor of Science 
 









Submitted to the Faculty of the Graduate 
College of Oklahoma State University in 
partial fulfillment of the requirements for the 
Degree of 
MASTER OF SCIENCE 
July 2005 
 ii
THE INFLUENCE OF SUPPLEMENTAL 
 
VITAMIN E AND ZINC ON THE 
 






             
 
 
             Thesis Approved: 
 
             Elizabeth Droke                                    
            Thesis Advisor 
 
             Brenda Smith                                        
 
 
          Tay Kennedy                                         
 
 
             A. Gordon Emslie                                  





 I would like to thank my graduate committee - Dr. Elizabeth Droke (Advisor), Dr. 
Tay Kennedy, and Dr. Brenda Smith – for their long lasting support in the completion of 
my research.  I would also like to express gratitude to the staff of the Nutritional Sciences 
laboratory and to the faculty of the Nutritional Sciences department at Oklahoma State 
University for all their help in completing this research. 
 My deepest thanks goes to my wonderful husband and daughter- for their support 
and understanding while I completed this research, and to my family for always being 





























II.  LITERATURE REVIEW.........................................................................................7 
 
Inflammatory Diseases.......................................................................................7 
Overview of the Immune System ......................................................................8 
Nutrition and Immunity ...................................................................................10 
Zinc ..................................................................................................................12 
Zinc Cellular Uptake........................................................................................15 
Zinc and Immunity...........................................................................................16 
Vitamin E .........................................................................................................19 
Vitamin E Cellular Uptake...............................................................................20 
Vitamin E and Immunity .................................................................................21 
Zinc, Vitamin E and Immunity ........................................................................24 
Pharmacological vs. Physiological Vitamin E and Zinc Concentrations ........26 
Hypotheses and Expected Results ...................................................................29 
 
 
 III. METHODOLOGY ...............................................................................................36 
 
Cell Culture......................................................................................................36 
Media Analysis ................................................................................................37 
Determination of the Optimal Cell Density .....................................................37 
Determination of the Optimal Zinc Supplementation......................................38 
Determination of the Optimal Vitamin E Supplementation ............................39 
Determination of the Optimal Lipopolysaccharide Challenge ........................41 
Determination of the Optimal Combination of Vitamin E and Zinc ...............42 
Determination of the Influence of Vitamin E and Zinc on Mouse Macrophage 
Response to a Lipopolysaccharide Challenge..................................................43 
Statistical Analyses ..........................................................................................45 
 
 IV.  RESULTS............................................................................................................47 
 
Determination of the Optimal Cell Density .....................................................47 
Determination of the Optimal Zinc Supplementation......................................48 
Determination of the Optimal Vitamin E Supplementation ............................48 
Determination of the Optimal Lipopolysaccharide Challenge ........................49 
Determination of the Optimal Combination of Vitamin E and Zinc ...............52
 v
 
Determination of the Influence of Vitamin E and Zinc on Mouse Macrophage  
Response to a Lipopolysaccharide Challenge..................................................54 
 
  V.  DISCUSSION ......................................................................................................73 
 
Determination of the Optimal Cell Density .....................................................73 
Determination of the Optimal Zinc Supplementation......................................73 
Determination of the Optimal Vitamin E Supplementation ............................74 
Determination of the Optimal Lipopolysaccharide Challenge ........................75 
Determination of the Optimal Combination of Vitamin E and Zinc ...............77 
Determination of the Influence of Vitamin E and Zinc on Mouse Macrophage 
Response to a Lipopolysaccharide Challenge..................................................78 
 
 VI.  SUMMARY, CONCLUSIONS, AND LIMITATIONS .....................................84 
 
VII.  BIBLIOGRAPHY ...............................................................................................88 
 
 vi




1.  P-values for the Growth of Macrophages in Vitamin E and Zinc Supplemented  
     Media after 24 and 48 Hours ..................................................................................62 
 
2.  Macrophage growth in Vitamin E and Zinc Supplemented medium at 24 Hours..63 
 
3.  Macrophage growth in Vitamin E and Zinc Supplemented medium at 48 Hours..65 
 
 vii
LIST OF FIGURES 
Figure Page 
 
 1.  Growth of macrophages in zinc supplemented medium........................................58 
 
 2.  Growth of macrophages in vitamin E supplemented medium...............................59 
 
 3.  Growth of macrophages in medium after challenge with Lipopolysaccharide (LPS)  
      from E. Coli 055:B5 (A) or E. Coli 0111:B4 (B) ..................................................60 
 
 4.  Nitric oxide production by macrophages in response to challenge with    
      Lipopolysaccharide (LPS) from E. Coli 055:B5 (A) or E. Coli 0111:B4 (B) .......61 
 
 5.  Growth of macrophages in vitamin E supplemented medium irrespective of zinc 
      supplementation .....................................................................................................64 
   
 6.  Growth of macrophages in vitamin E and zinc supplemented medium after a 24 
      (A) or 48 (B) hour exposure to LPS from E. Coli 055:B5.....................................66 
 
 7.  Nitric oxide produced by macrophages grown in zinc and vitamin E supplemented  
      medium after a 24 (A) or 48 (B) hour exposure to LPS from E. Coli 055:B5 ......67 
 
 8.  Nitric oxide produced by macrophages in response to a lipopolysaccharide challenge 
      of E. Coli 055:B5 in supplemented mediums ........................................................68 
 
 9.  Nitric oxide produced by macrophages in zinc and vitamin E supplemented mediums  
      for each lipopolysaccharide concentration.............................................................69  
 
 9.  Tumour necrosis factor alpha (TNF-α) production by macrophages grown in  
      vitamin E and zinc supplemented medium and challenged with LPS from E. Coli  
      055:B5....................................................................................................................70 
 
10.  Interleukin 10 (IL-10) production by macrophages grown in zinc and vitamin E  
       supplemented medium and challenged with LPS from E. Coli 055:B5 ...............71 
 
11.  Prostaglandin E2 (PGE2) production by macrophages grown in zinc and vitamin E  








Inflammatory diseases, such as rheumatoid arthritis, are a health problem in the 
United States.  It is estimated that 0.9 to 1.1% of the North American population suffers 
from rheumatoid arthritis alone (Alamanos & Drosos, 2005).  Sufferers of rheumatoid 
arthritis not only deal with pain, but also decreased daily functions (Wolfe et al., 1991) 
and depression (Nagyova et al., 2005).  Other inflammatory diseases include 
atherosclerosis and septic shock.  Septic shock is not only associated with death of the 
patient, but also with increased hospital costs and hospitalization time (Adrie et al., 
2005).  Atherosclerosis, which is a leading cause of strokes and myocardial ischemia 
(Sherwood, 1997), can also lead to increased medical costs and death.  Due to advances 
in medicine, mortality rates have declined, however, this means more people are living 
with this disease for longer periods of time (Reitsma et al., 1999). These inflammatory 
diseases are associated with increased concentrations of inflammatory mediators in the 
body (Simkin, 1976; Glauser et al., 1991; Wu et al., 2001).   
Inflammatory mediators are released during an immune response.  The immune 
response is triggered when a microbe penetrates the body’s first line of defense.  The 
body’s first line of defense includes the skin, mucus, bactericidal fluids, and gastric acid.  
When they penetrate the first line of defense, they are met by phagocytic cells, such as 
the macrophage (Roitt, 1991) through the innate immune response. The macrophage 
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destroys the invader through phagocytosis, during which, the macrophage releases 
several acute inflammatory response mediators, such as prostaglandin-E2 (PGE2), nitric 
oxide, tumor necrosis factor-α (TNF- α), interleukin-1 (IL-1), and IL-6.  These mediators 
are responsible for the redness and swelling associated with an inflammatory response.  
Increases in these mediators are also associated with inflammatory diseases, such as 
rheumatoid arthritis (Simkin, 1976), septic shock (Glauser et al., 1991), and 
atherosclerosis (Wu et al., 2001).   
It is well known that vitamin and mineral deficiencies can suppress immune 
responses, including innate immunity.  For example, zinc deficiency affects the immune 
system; Chandra et al (1984) observed zinc deficiency was linked to decreased 
macrophage function, while others observed zinc deficiency caused alterations in T-cell 
function and maturation (Rink & Gabriel, 2000; Prasad, 1998).  Supplementation of zinc 
has been shown to decrease the amount of nitric oxide produced in response to a 
lipopolysaccharide (LPS) challenge (Abou-Mohamed, et al., 1998).  Zinc 
supplementation has also been shown to decrease the amount of TNF-α and IL-1β 
produced (Driessen et al., 1995; Prasad, 2004).   
Another nutrient studied with the immune system is vitamin E.  Meydani and Han 
(2002) discussed how vitamin E acts as an antioxidant to increase lymphocyte 
proliferation, increase antibody response, and increase the number of helper T cells. 
Vitamin E supplementation has also been shown to decrease the amount of inflammatory 
response mediators released.  Supplementation with vitamin E has been shown to 
decrease the amount of PGE2, nitric oxide (Wu et al., 1998), IL-6 (Beharka et al., 2000), 
TNF-α, and IL-1β produced (Han et al., 2000; Devaraj & Jialal, 1998).         
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Studies have shown over-consumption of a nutrient may have a negative response 
similar to that of under-consumption; for example, an excess of zinc blocks T-cell 
function (Rink & Gabriel, 2000).  Therefore, research must determine what the optimal 
amount is to consume.  In addition to determining this optimal amount, researchers have 
to take into account interactions with other nutrients.   
Although micronutrients may be able to affect the immune response, the effects of 
interactions between various vitamins and minerals on the inflammatory immune 
response have not been thoroughly studied.  If two nutrients are known to have similar 
functions in the body (e.g. zinc and vitamin E both act to decrease nitric oxide produced 
(Abou-Mohamed, et al., 1998; Meydani et al., 2002)), then it must be determined what 
effect supplementation or depletion of both nutrients would have on that particular 
function.  To date, research has shown zinc is involved with the absorption of vitamin E 
(Hatfield et al., 2002; Noh & Koo, 2001; Kim et al., 1998), but has only begun to show 
how vitamin E and zinc work together in the immune system.  
Chandra et al. (1992) determined that supplementation with vitamin A, beta 
carotene, thiamin, riboflavin, niacin, zinc, copper, selenium, iodine, calcium magnesium 
and vitamins B6, B12, C, D, E could increase the antibody response to the influenza 
vaccine in independently-living elderly as compared to non-supplemented controls, as 
well as help protect against infection-related illnesses.  Girodon et al. (1999) showed in 
the institutionalized elderly that supplementation with both trace minerals (including 
zinc) and vitamins (including α-tocopherol) improved the humoral response after 
influenza vaccination to a greater extent when compared with vitamins alone or the 
control group.    However, it has not been shown how supplementation with both vitamin 
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E and zinc affect the release of inflammatory mediators due to the innate immune 
response.  The present study examined this relation by studying the influence vitamin E 
and zinc had on the response of the mouse macrophage to LPS.   
The overall goal of the present study was to determine the synergistic effect of 
vitamin E and zinc supplementation on the response of mouse macrophages (RAW 264.7 
cell line) to a LPS challenge.  Since LPS is found in the cell walls of bacteria, LPS 
challenges are used in cellular studies to simulate an infection with a gram-negative 
bacteria and the subsequent development of inflammation.  Therefore, the use of LPS 
will help to determine vitamin E and zinc supplementation’s synergistic effect on 
immune cells during inflammation.  This project will help determine if the combined 
supplementation of vitamin E and zinc would have a more beneficial effect on the release 
of pro-inflammatory response mediators (PGE2, nitric oxide, and TNF-α) and anti-
inflammatory response mediators (IL-10) than zinc or vitamin E supplementation alone.   
The overarching hypothesis was that the supplementation with both vitamin E and 
zinc would have a positive synergistic effect on the production of these mediators, and 
would decrease the release of the pro-inflammatory response mediators more than 
vitamin E or zinc supplementation alone.  It was expected that not only would the PGE2, 
nitric oxide, and TNF-α production be decreased by zinc supplementation and vitamin E 
supplementation alone, but would be decreased to a greater extent by supplementation 
with both the vitamin E and zinc.  It was also expected that IL-10 production would be 




Adequacy- refers to an animal, human or cell that has consumed or been provided with an 
amount of a nutrient to prevent the development of a deficiency. 
 
Deficiency- refers to a human or animal exhibiting overt clinical deficiency symptoms, as 
well as a measurable deficiency as determined by biochemical measures. 
 
Lipopolysaccharide- refers to a molecule found on the outer cell wall of Gram-negative 
bacteria (E. Coli for example). 
 
Marginal deficiency- refers to a state of deficiency that is only measured by biochemical 
analyses, and does not produce overt clinical symptoms.   
 
Pathogen- refers to an agent, such as a virus or bacteria, which can cause disease 
(Sompayrac, 1999).   
 
Pharmacological concentrations- refers to concentrations of nutrients in an organism that 
are brought about by supplementation of those nutrients that are higher than the normal 
physiological concentration.   
 
Physiological concentrations- refers to normal concentrations of a nutrient found in an 
organism that are maintained by adequate nutrient consumption.   
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Repletion- refers to providing an individual (animal, human or cell) that is deficient in a 
specific nutrient with that nutrient in order to restore the concentration of that nutrient in 
the organism or cell. 
 
Supplementation- refers to the provision of an additional quantity of a nutrient to an 





Inflammatory diseases, such as rheumatoid arthritis, septic shock and 
atherosclerosis, are major health problems in the United States.  The number of people 
suffering from these diseases is expected to increase over time due to an aging population 
and advances in health care that allow the person to live longer with the disease (Reitsma 
et al., 1999).   
It is estimated that 0.9 to 1.1% of the general population of the United States 
suffers from rheumatoid arthritis, but there is a greater prevalence among Native 
Americans (5.3 to 6.0 %) (Alamanos & Drosos, 2005).  Rheumatoid arthritis is caused by 
an imbalance of cytokines leading to chronic inflammation, which results in cellular 
damage (Choy & Panayi, 2001).  This cellular damage leads to destruction of cartilage 
and bone, thus leading to the development of rheumatoid arthritis (Choy & Panayi, 2001).  
Sufferers of rheumatoid arthritis not only suffer pain and functional disability (Wolfe et 
al., 1991), but suffer from depression and anxiety as well (Nagyova et al., 2005).  
Rheumatoid arthritis also leads to a decreased life expectancy of up to three to ten years 
(Alamanos & Drosos, 2005).  Treatment of the disease on average costs the patients 
approximately $5,919 each year, but the more severe the disease, the higher the costs 
(Yelin & Wanke, 1999).   
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In addition to rheumatoid arthritis, septic shock is an inflammatory disease that is 
a major health problem in the United States.  Septic shock occurs in 750,000 persons in 
the United States each year, of which approximately 28.6% of these cases ends in death 
of the patient (Angus et al., 2001), which makes it one of the major causes of death in 
critically ill patients (Adrie et al., 2005).  Angus et al. (2001) also estimated that the 
treatment costs per person who suffered septic shock were approximately $22,100 each 
year.   
Septic shock, as well as atherosclerosis and other inflammatory diseases, are 
associated with increased levels of nitric oxide, and many pro-inflammatory cytokines.  
In western countries, atherosclerosis is becoming more prevalent due to the higher rate of 
survival after an acute event (Reitsma et al., 1999).  Atherosclerosis is caused by the 
oxidation of LDL, which when taken up by macrophages causes lipid accumulation and 
formation of foam cells, and causes inflammatory mediators to be released (Witztum and 
Steinberg, 1991).  This accumulation leads to plaque formation, which can lead to 
blockage of blood flow in the heart or the brain (Sherwood, 1997), and lead to heart 
attack or stroke.  All of these diseases have been shown to be associated with increases in 
the pro-inflammatory mediators released by the macrophages (Simkin, 1976; Glauser et 
al., 1991; Wu et al., 2001); therefore, the present study was designed to determine if 
supplementation with vitamin E or zinc would decrease the production of pro-
inflammatory mediators.   
Overview of the Immune System 
 Innate immunity refers to the bodies’ first line of defense, which includes physical 
barriers, such as skin and mucous membranes.  These physical barriers help to prevent 
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pathogens, such as bacteria, from entering the body.  The skin is impermeable to bacteria 
unless injured, and produces sweat that contains fatty acids, which have a low pH that is 
unfavorable to bacteria.  The mucous membranes secrete mucus, which traps the bacteria, 
then is removed through coughing.  Other lines of defense include tears and saliva, which 
contain enzymes that damage the pathogens.  If a bacteria or other infectious agent 
penetrates these defenses, they are met by the phagocytes (Janeway et al., 2001).     
 The phagocytes include macrophages, monocytes, neutrophils, and a variety of 
other cells.  Monocytes are found in the blood, as are neutrophils, and both can move into 
the tissues.  Macrophages are formed when bone marrow promonocytes turn into blood 
monocytes, then move into the tissues to become macrophages (Janeway et al., 2001).    
Macrophages are the first host cells to respond to a pathogen in the body and 
engulf the pathogen through phagocytosis.  During phagocytosis, the pathogen adheres to 
the macrophage, and the macrophage wraps pseudopodia around the pathogen and forms 
a phagosome (Parkin & Cohen, 2001).  After the macrophage has engulfed the pathogen, 
the pathogen is joined with granules containing pre-formed mediators (e.g. IL-6 and 
TNFα) to become a phagolysosome and is then digested (Parkin & Cohen, 2001).  After 
digestion, the degradation products are released back into the body (Janeway et al., 
2001).  These degradation products signal to other immune cells that there is an invasion 
in the body, and helps to attract them to the site of the invasion (Sompayrac, 1999).  They 
also function to induce the proliferation of macrophages and natural killer cells 
(Sompayrac, 2001).        
 The macrophage also secretes mediators of the acute inflammatory response such 
as IL-1, TNF, PGE2, and neutrophil chemotactic factor.  Several of these cytokines that 
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are produced by the macrophage have been shown to produce reactive oxygen species 
(ROS) (Ozaki et al., 1987), which causes oxidative stress in the body.  Prostaglandin-E2 
also decreases T-cell proliferation as well as IL-2 production (Goodwin & Ceuppens, 
1982).    
 The type of immunity previously discussed was innate immunity; the other type 
of immunity in the human body is specific acquired immunity or adaptive immunity.    
Innate immunity is quick to destroy invaders but is non-specific and can lead to tissue 
damage, where acquired immunity is specific but does require a long time to destroy 
invaders (Parkin & Cohen, 2001).  Mediators of innate immunity signal and activate the 
adaptive response and aid in determining the type of adaptive response that should occur.   
 Thus, innate and adaptive immunity work together to protect the body from 
infection.  The present study focused on the macrophage (innate immunity), and its 
secretion of pro-inflammatory mediators in response to LPS.  These pro-inflammatory 
mediators have been linked to various inflammatory diseases, such as septic shock 
(Glauser et al., 1991) and rheumatoid arthritis (Simkin, 1976); therefore, a decrease in 
these pro-inflammatory mediators is desired.  The present study was designed to 
determine if zinc and vitamin E supplementation had a synergistic affect on the amount 
of these pro-inflammatory agents produced.         
Nutrition and Immunity 
 Nutrition in immunology has been studied extensively, but mostly in aspects of 
how a single nutrient affects the immune system (Kubena & McMurray, 1996).  For 
example, vitamin A supplementation of rats has been shown to increase the phagocytic 
activity in Kupffer’s cells (Olson, 1986).  Vitamin A has also been shown to control the 
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proliferation and differentiation on various other cells in the immune system (Olson, 
1986).  Supplementation of children with a single large amount (100,000 to 200,000 IU) 
of vitamin A was found to increase IL-1 production and cytotoxic functions of 
macrophages (Bhaskaram et al., 1989).  Another vitamin that has been studied for its 
affects on the immune system is vitamin C.  Vitamin C supplementation has been 
associated with enhanced human natural killer cell activity in patients that were exposed 
to toxic chemicals (Heuser & Vojdani, 1997), as well as enhanced phagocytosis by 
neutrophils in elderly women (Herbaczynska-Cedro et al., 1994).  Vitamin E has also 
been studied in regards to the immune system, and these results will be discussed in the 
subsequent sections.   
 Trace elements have an affect on the immune system as well.  For example, iron 
deficiency has been shown to affect cell-mediated immune function among pregnant 
women (Prema et al., 1982).  Magnesium also affects cell-mediated immune function, as 
well as humoral immunity (Kubena, 1993).  Other trace minerals often studied in regards 
to the immune system include selenium, zinc and copper.  Selenium deficiency has been 
associated with increased rat macrophage production of PGE2, as has vitamin E 
deficiency (Eskew et al., 1989).  Copper deficiency, which can be induced by over 
supplementation with zinc, has been shown to decrease the function of neutrophils in 
humans (Percival, 1995).  Zinc has also been extensively studied, and will be discussed in 
the subsequent sections.     
 In addition to vitamin and mineral effects on the immune system, fatty acids have 
been shown to have effects on the immune system (Kubena & McMurray, 1996), by 
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changing the fatty acid composition of immune cell membranes, lymphocyte proliferation 
as well as function can be affected (Calder & Newsholme, 1993).   
 Some interactions between two nutrients have been studied in regards to immune 
functions.  For example, supplementation with both Vitamin A and vitamin D has been 
associated with increased phagocytic activity of U 937 human macrophages, as well as 
enhanced oxidative burst (Tiami et al., 1991).  The interactions zinc and vitamin E have 
with other nutrients will be discussed in subsequent sections.      
Zinc  
Zinc has several functions in the body, from taste acuity, to reproduction, to 
immunity.  Zinc can be found in body fluids, tissues and organs, including the bone, 
muscle and skin.  Zinc is believed to be involved with over 200 enzymes in the human 
body, mostly as a part of metalloenzymes (Groff & Gropper, 1999).   
These enzymes are involved in tissue and cell growth, vision, digestion, 
membrane stabilization, metabolism, bone formation and skin integrity.  Zinc is also 
necessary to bind certain proteins to deoxyribonucleic acids (DNA) - zinc provides 
structure to the “zinc fingers” proteins, thus allowing them to be able to bind with DNA 
(Groff & Gropper, 1999).  Zinc is also needed for structure of cells since it is a 
component of the microtubules that provide the structure for the cells. (Groff & Gropper, 
1999).  Zinc is also important in bone metabolism - it has been shown that zinc aids 1,25-
dihydroxy vitamin D3 in bone metabolism, and stimulates protein synthesis (Yamaguchi 
& Inamoto, 1986).  1,25-dihydroxy vitamin D3 functions with parathyroid hormone to 
regulate bone remodeling in the body (Li & Farach-Carson, 2001).       
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Zinc is also found in superoxide dismutase (SOD), which acts to remove 
superoxide radicals (such as O2-) from the body (Groff & Gropper, 1999); therefore, 
reducing oxidative damage to the body.  These superoxide radicals (O2-), along with 
H2O2 and OH are referred to as reactive oxygen species (ROS), which can lead to 
oxidative stress in the body.  Oxidative stress has been shown to be involved with 
atherosclerosis, cancer, and immunologic disorders (Prasad, 2004).  Zinc reduces the 
ROS during several steps of their formation.  For example, zinc hinders NADPH, which 
catalyzes the production of O2- from oxygen (Prasad, 2004).  Another way zinc reduces 
the ROS is through metallothionein, which reduces the amount of OH.  Because zinc 
competes with iron and copper (which catalyze the production of OH), zinc reduces the 
amount of OH formed through that route also (Prasad, 1998).   
Zinc is involved with human digestion through the enzymes carboxypeptidase A 
and aminopeptidase, which are both involved in protein digestion through the digestion 
of peptide bonds (Groff & Gropper, 1999).  Zinc is also involved with metabolism, and is 
a part of insulin, which is critical in regulating glucose metabolism (Groff & Gropper, 
1999).    
Zinc deficiency is a growing world problem due in part to poor zinc intake, and 
high intake of phytates and phosphates which hinder zinc absorption (Prasad, 1961).  
Over two billion people may currently be suffering from zinc deficiency worldwide 
(Prasad, 1998).  Because zinc is involved with so many different aspects of the human 
body, the deficiency of it has been linked to a wide variety of abnormalities in the body.  
For example, zinc deficiency has been linked to growth retardation, embryonic 
abnormalities (Hurley & Swenerton, 1966), testicular atrophy (Prasad, 1961), epidermal 
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hyperkeratinization, chronic diarrhea, delayed wound healing, and loss of both hair and 
taste (Prasad, 1998).      
Zinc deficiency in pregnant women is of major concern due to the growing fetus’s 
demand for zinc and the mother’s need for it as well.  It has been linked to prolonged 
gestation periods, poor labor, and increased maternal morbidity, along with the risks to 
the fetus; however, zinc supplementation was able to decrease all of these risks (Jameson, 
1982).  In studies performed using rats as the model, it was found that there is an increase 
in central nervous system malformations among those who are zinc deficient (Hurley & 
Swenerton, 1966).  Women, who have acrodermatitis enteropathica, have a higher 
incidence of fetuses with congenital malformations as well (Prasad, 1998).  Goldenberg 
et al. (1995) showed that women of lower body mass index (less than 26 kg/m2), who 
also had low plasma zinc concentrations, had babies with a greater birth weight and head 
circumference when supplemented with zinc.        
Zinc is very important in human reproduction not only for women, but for men 
also.  Zinc deficient males are subject to decreased serum testosterone levels (Prasad, 
1996), as well as hypogonadism (Prasad, 1961).          
Ninh et al (1995) reported a decrease in weight gain, insulin-like growth factor-1 
(IGF-1), hepatic growth hormone receptors, and serum growth hormone-binding protein 
(GHBP) in rats that were zinc deficient.  Either the decrease in GHBP or the decrease in 
hepatic growth hormone receptors is believed to have caused the decrease in IGF-1.  In a 
separate study, Ninh et. al. (1996) showed zinc repletion led to an increase in IGF-1, 
weight and height among zinc deficient Vietnamese children.  A zinc deficient diet has 
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also been shown to lead to a decrease in the basal metabolic rate and in thyroid hormones 
(Wada & King, 1986).     
Zinc supplementation and repletion have been studied in connection with the 
common cold, respiratory viruses, pneumonia (Bhutta et al., 1999), diarrhea (Hambidge, 
2000; Bhutta et al., 2000), aortic aterogenesis (Alissa et al., 2004) and Wilson’s disease 
(Yuzbasiyan-Gurkan et al., 1992).  Repletion of body zinc concentrations has also been 
shown to be both effective in decreasing the duration and severity of both acute and 
persistent diarrhea, as well as the death rate associated with diarrhea in children in 
developing countries (Bhutta et al., 2000).  The prevalence of pneumonia was also shown 
by Bhutta et al. (1999) to be decreased in children in developing countries, who had low 
zinc concentrations, after receiving zinc supplementation. Alissa et al. (2004) showed that 
zinc or copper supplementation decreased aortic atherogenesis in animals fed a 
cholesterol diet through a reduction in the aortic lesion area. 
Over supplementing with zinc has been linked to copper deficiency in some 
individuals (Prasad et al., 1978).  Since this discovery, there have been studies conducted 
to see if zinc supplementation could be used to treat Wilson’s disease (Brewer et al., 
1983; Brewer et al., 1987; Brewer et al., 1990; Hill, et al., 1987), which is an inherited 
disorder resulting in copper excess (Prasad, 1998).  Zinc is able to prevent the copper 
from being absorbed by activating an intestinal metallothionein, which binds the copper 
and helps to excrete it from the body (Yuzbasiyan-Gurkan et al., 1992).   
Zinc Cellular Uptake 
Zinc uptake by cells occurs in two phases, which are rapid and slow uptake 
(Stacey & Klaasen, 1981).  The rapid uptake of zinc by fetal type II pneumocytes occurs 
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within thirty seconds of adding the zinc treated media to the cells, while the slow uptake 
still doesn’t reach equilibrium within sixty minutes (Ong et at., 1995).  Chvapil et al. 
(1977) demonstrated that rat peritoneal macrophages incubated with 50 µM zinc had zinc 
concentrations that increased continuously during the entire incubation time of 30 
minutes.  These macrophages had a zinc content of 2.3 µg/108 cells at zero minutes, and 
increased to a zinc content of 8.0 µg/108 cells at thirty minutes (Chvapil et al., 1977).  
This zinc uptake is not only affected by time, but also by zinc concentration (Chvapil et 
al., 1977) and the zinc status of the cell (McClung and Bobilya, 1999).      
The affects of different zinc concentrations on the uptake of zinc to cells have also 
been studied.  When the rat peritoneal macrophages were incubated with increasing 
amounts of zinc (0 to 800 µM) with and without serum, the zinc uptake of the cells within 
twenty minutes increased as the zinc concentration increased; however, the presence of 
serum decreased the zinc content found in the cells (Chvapil et al., 1977).    
Zinc status of the cells also affects the uptake of zinc.  McClung and Bobilya 
(1999) demonstrated that zinc status of the porcine endothelial cell also affects zinc 
uptake; the zinc-deficient porcine endothelial cells uptake zinc faster than the zinc 
adequate and zinc supplemented porcine endothelial cells.  These researchers also 
showed that zinc supplementation of 5, 25, 50 and 75 µmol/L showed similar zinc uptake 
rates in cells supplemented with 5, 25, and 50 µmol/L, but a decreased uptake rate in cells 
supplemented with 75 µmol/L (McClung and Bobilya, 1999).       
Zinc and Immunity 
Zinc deficiency in known to affect the immune system.  Zinc deficiency can be 
linked to an increase in cases of diarrhea (Bhutta et al., 2000), as well as delayed wound 
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healing (Lim et al., 2004).  Zinc deficiency has also been linked to thymic atrophy, 
lymphopenia, and anergy (Beck et al., 1997; Prasad, 1998; Rink & Gabriel, 2000).   
Zinc is important in innate immunity through a variety of functions.  Zinc 
deficiency has also been linked to decreased macrophage function (Chandra, 1984), as 
well as the decreased activity of natural killer cells (Rink & Gabriel, 2000; Beck et al., 
1997).  Although research in zinc deficiency and immune function has been studied for 
several years, only recently has zinc supplementation become a key focus.          
Prasad et al. (2004) demonstrated that in human mononuclear cells, zinc 
supplementation helped protect the cells against oxidative stress by decreasing the TNF-α 
induced binding of nuclear factor κB, as well as decreasing the gene expression of TNF-α 
and IL-1β both of which are associated with oxidative stress.  Similar to Prasad et al. 
(2004), Driessen et al. (1995) found zinc supplementation decreased the amount of TNF-
α produced by monocytes and IL-1β after stimulation by staphylococcal enterotoxins A 
and E in polymorphonuclear cells and whole blood cells of humans.  These decreases in 
pro-inflammatory mediators demonstrate that zinc has anti-inflammatory properties.   
Zinc supplementation of 100 and 150 µM has also been shown to decrease the 
nitric oxide, another pro-inflammatory mediator, produced by isolated rat aortic smooth 
muscle cells after the rats had been challenged with LPS from E. Coli 0127:B8 at 5-
mg/kg body weight (Abou-Mohamed, et al., 1998).  Because increases in nitric oxide are 
associated with inflammatory diseases, this decrease in nitric oxide production due to 
zinc supplementation also demonstrates zinc’s anti-inflammatory properties (Abou-
Mohamed, et al., 1998).   
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Research has found zinc supplementation leads to an increase in the amount of 
IL-1β and TNF-α when polymorphonuclear cells from healthy human donors are 
stimulated with LPS from E. Coli 0111:B4, but not when they were stimulated with 
phytohaemaglutinin (PHA) (Driessen et al., 1995).  This increase in monokine secretion 
leads to T-cell activation (Driessen et al., 1995).  The T-cells then seek out body cells that 
contain microbes and helps to destroy the cell that contains the microbe, or in the case of 
macrophages, reactivates the cell to start killing the microbes again (Roitt, 1991).   
   While zinc supplementation leads to the increase of these monokines, Lastra et 
al. (2001) has shown that zinc supplementation enhances the macrophage’s phagocytic 
index at six weeks of supplementation.  It decreases this index at nine weeks of zinc 
supplementation in mice, showing that the longer time leads to saturation of the zinc 
binding sites on the macrophage.  This over-saturation may impair the immune system 
(Lastra et al., 2001).   The phagocytic index is an average of the amount of bacteria 
ingested by each phagosome (http://www.infoplease.com); therefore, the greater the 
phagocytic index, the greater the amount of microbes destroyed by each phagosome.   
Zinc also has been shown to have an effect on LPS, which is found in the walls of 
gram-negative bacteria, due to a direct interaction with the LPS.  Zinc decreases the 
fluidity of LPS’s hydrocarbon chains, which when decreased causes the LPS to induce 
the formation of less monokines (Wellinghausen et al., 1996). 
Zinc also affects cell-mediated immunity.  Zinc-deficient humans are known to 
have a decreased production of IL-2 and tumor necrosis factor-α  (TNF-α) (Prasad, 
1988); however, the production of IL-4, IL-6, and IL-10 are unchanged by zinc 
deficiency suggesting that zinc may have more of an affect on T helper cell response- 
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type 1 (TH1) cells (Beck et al., 1997), which through IL-2 induces T cell proliferation 
(Parkin & Cohen, 2001). 
Zinc is also needed as a part of a cofactor for thymulin, which helps aid T 
lymphocyte maturation (Shankar & Prasad, 1998), and a deficiency of zinc decreases 
thymulin activity (Prasad et al., 1988).  Zinc deficiency has been suggested to cause a 
decrease in both T and B lymphocytes by both reducing their ability to function properly 
and by increasing cell death (apoptosis) (Berger, 2002).  In animal studies using mice, 
Fraker et al. (1978) was able to demonstrate that the T- cell helper function that was 
impaired due to zinc deficiency, could be restored with zinc supplementation, as could 
thymus size within two weeks of starting supplementation.  King & Fraker (2002) 
indicated zinc deficiency disrupted erythropoiesis and lymphopoiesis, but not 
myelopoiesis in mice, which might indicate that the body protects innate immunity more 
than adaptive immunity in response to a zinc deficiency.      
Excessive zinc supplementation, however, has been shown to have detrimental 
effects on the immune system as well.  Lim et al. (2004) found zinc dietary 
supplementation of 1000 µg/g diet to decrease TNF-α mRNA levels, and to delay wound 
healing in mice, although zinc supplementation of 500 µg/g diet had beneficial effects.   
Chandra (1984) found that excessive intakes of zinc in healthy men impaired chemotaxis 
and phagocytic activity of neutrophils against bacteria.   
Vitamin E  
Vitamin E is a fat soluble vitamin that acts as an antioxidant in the body.  The 
main function of vitamin E is to maintain membrane integrity of the cells, which it does 
by preventing oxidation of the unsaturated fats that are found in the phospholipids in the 
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cell membrane.  The cells in the lungs and brain, and erythrocytes have membranes that 
are high in unsaturated fatty acids, making them more likely to be oxidized (Groff & 
Gropper, 1999).  Vitamin E is a free radical scavenger, which helps protect the integrity 
of the cell.    
As an antioxidant, vitamin E has been thought to aid in the treatment of cataracts 
since it is believed that cataracts are caused from oxidative damage to the proteins in the 
eye (Groff & Gropper, 1999).  Also, it is believed that vitamin E supplementation can 
help in the treatment of diabetes mellitus by improving the glucose transport function 
(Whiteshell et al., 1989).   
Vitamin E is also believed to aid in decreasing the risk of atherosclerosis.  Gale et 
al. (2001) showed a diet high in antioxidants, including vitamin C, vitamin E and β-
carotene, was associated with a decreased development and growth of atherosclerotic 
lesions in men.  Diets higher in vitamin E have also been associated with higher cognitive 
function in the elderly (Ortega et al., 2002).   
It was found in previous studies that vitamin E deficiency causes red blood cell 
hemolysis, and causes an increase in natural killer cell activity (Klurfeld, 1993), but this 
could be decreased by supplementation with vitamin E (Adachi et al., 1997).    
A vitamin E deficiency rarely occurs in humans, except for premature infants, but 
can occur in people with malabsorption diseases and people with abetalipoproteinemia (a 
genetic disease in which the person lacks apolipoprotein B) (Groff & Gropper, 1999).   
Vitamin E Cellular Uptake 
Vitamin E uptake by cells varies among types of vitamin E.  Gao et al. (2002) 
showed that in the RAW 264.7 macrophage cell line γ-tocopherol uptake was six times 
 21
greater than that of α-tocopherol.  Saito et al. (2004) also showed that in Jurkat E6-1 cells 
(human T-leukemia cells) α-tocotrienol uptake was 70 times higher than that of α-
tocopherol; however, the uptake of α-tocotrienol leveled out after only six hours, while 
the α-tocopherol uptake still had not leveled out after 72 hours.  McCormick and Parker 
(2004) however showed no difference in uptake of α-tocopherol as compared to δ-
tocopherol within cell types; however, they showed that after six hours of incubation with 
these tocopherols, human hepatocytes had a uptake that was 20% of that of the RAW 
264.7 mouse macrophages.   
Gao et al. (2002) showed that α-tocopherol uptake by the cells increased 0.15 
nmoles/well after six hours of incubation with 5.6 µM α-tocopherol; however, Saito et al. 
(2004) showed uptake levels of α-tocopherol had still not leveled out by 72 hours, so this 
was a relatively short incubation time to measure.     
Vitamin E and Immunity 
 Vitamin E supplementation has been hypothesized to help in many diseases, such 
as atherosclerosis, which is influenced by pro-inflammatory mediators, such as PGE2 and 
thromboxane B2 (Wu et al., 2001).  Supplementation with vitamin E has been shown to 
decrease many of these pro-inflammatory mediators (Wu et al., 2001), thus possibly 
decreasing atherosclerosis development.  As stated earlier, other inflammatory diseases 
are related to increases in a variety of inflammatory mediators.      
Some examples of these inflammatory mediators are nitric oxide and PGE2.  
Vitamin E supplementation decreased the amount of nitric oxide and PGE2 produced in 
mice when stimulated with LPS (Beharka et al., 2000).   Another researcher was also able 
to show this decrease in nitric oxide in a rat in vivo and in vitro study (Khanduja et al., 
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2004).  It was determined that by decreasing nitric oxide production, vitamin E 
supplementation decreased LPS-stimulated PGE2 production through the inhibition of 
COX activity (Wu D et al, 1998); thus the decrease of nitric oxide production was what 
lead to the decrease in PGE2 production.  Since, PGE2, and nitric oxide are known to be 
involved in the inflammation process by decreasing production of these inflammatory 
mediators, the risk for inflammatory diseases decreases.  Jensen et al. (1988) observed 
that vitamin E deficiency caused an increase in PGE2 production, which would be an 
undesirable outcome.   
Another inflammatory mediator is IL-6.  Beharka et al. (2000) showed vitamin E 
supplementation decreased the amount of IL-6 in un-stimulated mouse macrophages, 
which would be a another desirable decrease.   
Other inflammatory mediators shown to be decreased by vitamin E 
supplementation include IL-1β and TNF-α (Han et al., 2000).  These were shown to be 
decreased in mice fed vitamin E supplemented diets as compared to those fed non-
supplemented diets in response to a Con-A challenge (Han et al., 2000).  Devaraj and 
Jialal (1998) were able to determine that the decrease in IL-1β release is due to the 
inhibition of the 5-lipoxygenase pathway.  Increases in IL-1β have been found in the 
coronary arteries of people with ischemic heart disease (Galea et al., 1996); therefore, a 
decrease in its levels is desired.    
  In addition to acting in innate immunity to decrease the amount of pro-
inflammatory mediators produced, vitamin E acts in both cell-mediated and humoral 
immunity.  In cell mediated immunity, deficiency of vitamin E has been shown to 
decrease lymphocyte proliferation after stimulation with concanavalin A (ConA) and 
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phytohemagglutinin (PHA) (Eskew et al., 1986).  This decrease may be due to decreased 
IL-2 production.  IL-2 is needed to induce T cell proliferation; therefore, decreased 
concentrations of IL-2 would lead to decreased concentrations of T-cells made in 
response to an antibody.  Harris et al. (1980) found this to be true in rats fed a vitamin E 
deficient diet; the rats produced lower amounts of IL-2 in response to PHA and ConA, 
and lower levels of levels of lymphocytes.  A positive effect is seen with vitamin E 
supplementation, Sakai & Moriguchi, (1997) showed rats supplemented with vitamin E 
were able to increase their IL-2 production and lymphocyte proliferation in response to 
PHA and ConA.  Han et al. (2000) also showed an increase in IL-2 production in 
response to LPS in older mice supplemented with vitamin E.   
  In cell-mediated immunity, Moriguchi (1998) showed that vitamin E 
supplementation increased T-cell differentiation in the thymus, thereby, enhancing 
thymic lymphocyte proliferation.  Since supplementation of vitamin E lead to increased 
T-cell differentiation, Moriguchi (1998) hypothesized that supplementation with vitamin 
E could result in faster recoveries of patients with bone marrow transplants by increasing 
differentiation of transplanted bone marrow cells making hospital stays shorter, which 
would decrease medical costs.   
Vitamin E’s affect on humoral immunity has been shown as well.  When vitamin 
E is added in place of some of the mineral oil in vaccines, the antibody response is faster 
than when vitamin E is not used in the vaccine (Franchini et al., 1995); therefore, 
affecting humoral immunity.  
Another way vitamin E affects the immune system is through interferon-γ.   
Interferon-γ (IFN- γ), which induces macrophage activation (Portillo et al., 1989),  was 
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shown by Han et al. (2000) to be increased in response to a challenge with LPS in 
vitamin E supplemented older mice.  However, Pallast et al. (1999) reported decreased 
amounts of IFN-γ produced in response to vitamin E supplementation.   
Vitamin E also exhibits its antioxidant properties in the immune system by 
decreasing the amount of reactive oxygen species (ROS) released by macrophages 
(Pathania et al., 1999).  Supplementation with α-tocopherol acetate has been shown to 
decrease the amount of O2- and H2O2 (known as the ROS) that are released by alveolar 
macrophages in response to a LPS challenge (Pathania et al., 1999). 
Vitamin E works well with other antioxidants as well; for example, 
supplementation with both vitamin E and vitamin C has been shown to help lower the 
risk of developing dementia and Alzheimer’s disease but not with either one alone 
(Aubertin, 2004).  Supplementation with both vitamin C and vitamin E has also been 
shown to decrease arachidonic acid production in an in vitro study (ElAttar & Lin, 1992).  
Vitamin E and selenium supplementation was also shown to decrease ethane production 
due to lipid peroxidation in response to a LPS challenge (Sword et al., 1991). 
Zinc, Vitamin E and Immunity 
Vitamin E and zinc are known to have several of the same functions, such as 
membrane stabilization, but their interactions have not been studied thoroughly at this 
time.  Many of the interaction studies have focused on how the deficiency of zinc causes 
a decreased absorption of vitamin E, as well as other lipid soluble vitamins (Kim et al., 
1998), and how a zinc deficient diet can lead to lower levels of α-tocopherol in the liver, 
kidney, heart, brain and testis (Noh & Koo, 2001).  Hatfield et al. (2002) did show that 
zinc helped to increase the absorption or retention of vitamin E in the pig, but did not find 
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vitamin E and zinc supplementation to have any interactions other than that.  Since both 
nutrients are important in the immune system, it is important to know if they do act 
synergistically, and if supplementation is beneficial.   
Supplementation studies with both vitamin E and zinc have been done to 
determine their affects on certain disease states, such as macular degeneration (Jampol & 
Ferris III, 2001).  Supplementation with zinc, vitamin E and other antioxidants was found 
to help reduce the chances of developing age-related macular degeneration and 
development of moderate visual acuity loss, as was zinc alone; however, the study did not 
show if zinc alone was better or if zinc combined with the vitamins was better at reducing 
these risks (Jampol & Ferris III, 2001).  
Studies have also been done to determine if vitamin E supplementation can help 
to overcome some of the deleterious affects of a zinc deficient diet.  Kraus et al. (1997) 
found that supplementation with antioxidants such as vitamin C, vitamin E, and β-
carotene, did improve the osmotic fragility of erythrocytes associated with zinc 
deficiency, with vitamin C having the most affect.  Bettger et al. (1980) found that 
supplementation with antioxidants (including vitamin E) could improve the skin lesions 
found in chicks with zinc deficiency, as well as decrease the thiobabituric acid-reactive 
substances (TBARS).  
 Zago & Oteiza (2001) also showed a decrease in iron initiated TBARS formation 
in zinc sufficient animals due to supplementation with both α-tocopherol and zinc, a 
greater decrease was found with the combination of α-tocopherol and zinc than with 
either one alone.  When combined with a water soluble antioxidant iron induced lipid 
oxidation was prevented completely.   
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  Chandra et al. (1992) also determined that supplementation with vitamin A, beta 
carotene, thiamin, riboflavin, niacin, zinc, copper, selenium, iodine, calcium magnesium 
and vitamins B6, B12, C, D, and E could increase antibody response to the influenza 
vaccine as compared to non-supplemented controls, as well as help protect against 
infection-related illnesses.  Girodon et al. (1999) also showed supplementation with trace 
minerals and vitamins improved the humoral response in the elderly after vaccinations for 
influenza in groups treated with both trace minerals (including zinc) and vitamins 
(including α-tocopherol) more than vitamins alone or the control group.  Because zinc is 
believed to be important for the maintenance of natural killer cells, and vitamin E 
deficiency is associated with an increase in natural killer cell activity, zinc and vitamin E 
are hypothesized to act together on some functions of the immune system.  Investigators 
have observed supplementation of vitamin E or zinc decrease the amount of PGE2 and 
nitric oxide, respectively, produced by macrophages (Wu D et al., 1998 & Abou-
Mohamed et al., 1998).  However, it is unclear how the interactions between zinc and 
vitamin E affect the production of PGE2 and nitric oxide.  The present study evaluated the 
interaction between the zinc and vitamin E in order to determine if the two act 
synergistically to enhance the reduction of PGE2 and nitric oxide produced by stimulated 
macrophages.  
Pharmacological vs. Physiological Vitamin E and Zinc Concentrations 
In the present study, the media used was already zinc and vitamin E adequate, so 
the present study only looked at the effects of supplementation with vitamin E and zinc 
on zinc and vitamin E adequate cells.  Combined with the amount of vitamin E and zinc 
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found in the media, the supplementation levels that were used included both 
pharmacological and physiological concentrations.     
  The normal physiological range of zinc in the serum is 0.69 to 1.49 mg/L (Faber 
et al., 2004), or 10.6 to 22.78 µmol/L.  Treatment with pharmacological concentrations of 
zinc (levels that can only be obtained through consumption of supplements), can lead to 
the serum zinc concentrations increasing above the normal physiological range.  Estefan 
et al. (1998) showed that in patients with hypopituitarism that consumed a zinc adequate 
diet (12 mg/day), and consumed 165 mg zinc sulfate supplements had an increased serum 
zinc concentration of 3.04 ± 0.81 µg/mL after 120 minutes.  Faber et al. (2004) showed 
one week of zinc supplementation with 80 mg zinc sulfate a day did increase zinc serum 
concentrations, but not above physiological concentrations.   
Information from the Third National Health and Nutrition Examination Survey 
(NHANES III) shows that the average zinc intake from diet is 14 mg/day for men and 9 
mg/day for women with the highest amount from food being 24 mg/day.  The average 
intake from both food and supplements for both genders is 13 mg/day (198.75 µmol/day).  
The upper intake level ranges from 40 mg/day for adults to 7 mg/day for 1-3 year-olds. 
The normal physiological range of vitamin E in serum or plasma ranges from 12-
42 µmol/L, or 0.5 to 1.8 mg/dL.  Gaede et al. (2001) showed vitamin E supplementation 
of 680 IU combined with vitamin C supplementation of 1250 mg for four weeks in 
patients with Type 2 diabetes increased serum concentrations of vitamin E, but these 
serum concentrations were not above the physiological range.      
Average vitamin E intake from food according to the NHANES III, was 17.44 
µmol per day, and the average intake from both supplements and diet (pharmacological 
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amounts) was 59.75 µmol per day.  The upper intake level ranges from 2325 µmol/day 
for adults to 465 µmol/day for 1-3 year-olds.     
The present study consisted of six separate experiments.  The first experiment was 
determination of the optimal cell seeding density to use for the subsequent experiments, 
followed by an experiment determining the optimal zinc supplementation concentration 
and one determining the optimal vitamin E supplementation concentration.  An 
experiment was also done to determine which strain of LPS to use, and which 
concentration of this LPS to use.  A combination study of zinc and vitamin E 
supplementation was also completed.  All of these studies were used to determine 
different components of the final study that looked at the synergistic effect of 
supplementation of both vitamin E and zinc on the response of the mouse macrophage to 
an LPS challenge.   
            
   
 29
Hypotheses and Expected Results 
 
I. Determination of Optimal Cell Density 
 
A. Hypothesis: The seeding density of 1 x 104 cells/well in a 96 well plate 
will provide the most desired optical density (used as an indicator of 
growth) of the seeding densities. 
1. Expected Results: A greater seeding density will lead to a greater   
optical density.   
II. Determination of Optimal Zinc Supplementation 
A. Hypothesis: The 50 µM zinc concentration will provide the most desired 
optical density (used as an indicator of growth) of the cells as compared to 
all of the other zinc concentrations (0, 10, 100 and 500 µM). 
1. Expected Results: The lower zinc concentrations, 0 and 10, will 
have a lesser optical density, or amount of growth, than the cells 
in the 50 µM zinc concentration.   
2. Expected Results: The zinc concentrations greater than or equal 
to 100 µM will have a lower amount of growth, or optical 
density, than the cells in the 50 µM zinc concentration.   
III. Determination of Optimal Vitamin E Supplementation 
A. Hypothesis: The 50 µM vitamin E concentration will provide the most 
desired optical density (used as an indicator of growth) of the cells as 
compared to the other vitamin E concentrations (0, 25 and 100 µM).   
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1. Expected Results: The cells in the lower vitamin E 
concentrations (0 and 25 µM) will have a lesser optical density 
than the cells in the 50 µM vitamin E concentration. 
2. Expected Results: The cells with the highest concentration of 
vitamin E (100 µM) will have a lesser amount of growth, or 
optical density, than the cells in the 50 µM vitamin E 
concentration.   
IV. Determination of Optimal LPS Challenge 
A. Hypothesis: The LPS from E. Coli 055:B5 and 0111:B4 strains will cause 
the macrophages to produce significantly different amounts of nitric oxide. 
1. Expected Results: LPS from the E. Coli 055:B5 will produce a 
different amount of nitric oxide than LPS from E. Coli 0111:B4. 
B. Hypothesis: The 100 µg/mL LPS concentration will produce the greatest 
amount of nitric oxide.   
1. Expected Results: The greater LPS challenge concentration will 
lead to a greater amount of nitric oxide produced. 
2. Expected Results: The 0 µg LPS concentration will not produce a 
measurable amount of nitric oxide after any of the time points. 
C. Hypothesis: The cells challenged with LPS from E. Coli 055:B5 will have 
a greater optical density (used as an indicator of growth) after 24 and 48 
hours as compared to the cells challenged with LPS from E. Coli 0111:B4.   
D. Hypothesis: The cells challenged with 100 µg LPS/mL will have a lower 
optical density than the cells challenged with the other concentrations.    
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1. Expected Results: The cells challenged with the higher LPS 
concentrations (5, 10, 50, and 100 µg LPS/mL) will have a lower 
optical density than those challenged with the lower 
concentrations (0.1 and 1.0 µg LPS/mL).   
2. Expected Results: The cells not challenged with LPS will have a 
lower optical density than those challenged with the lower LPS 
concentrations (0.1 and 1.0 µg LPS/mL).   
V. Determination of the Optimal Combination of Vitamin E and Zinc   
A. Hypothesis: The cells supplemented with both 50 µM zinc and 50 µM 
vitamin E will have a greater optical density (used as an indicator of 
growth) than the cells supplemented with the other supplementation 
combinations.   
1. Expected Results: The cells supplemented with the greatest 
amount of zinc (100 µM) and the lower amounts of zinc (0 and 
10 µM) will have a lower optical density than those 
supplemented with the 50 µM zinc concentrations. 
2. Expected Results: The cells supplemented with 50 µM vitamin E 
will have a greater optical density than the cells with the greatest 
concentration of vitamin E (100 µM) and the lowest amounts of 
vitamin E (0 and 25 µM).   
3. Expected Results: The cells supplemented with both 50 µM zinc 
and 50 µM vitamin E will have a greater amount of growth than 
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those supplemented with 0 µM zinc/50 µM vitamin E and 50 µM 
zinc/0 µM vitamin E.   
VI. Determination of the Influence of Vitamin E and Zinc Supplementation on the 
Response of Mouse Macrophages to a LPS Challenge 
A. Hypothesis: The cells supplemented with the combination of 50 µM zinc 
and 50 µM vitamin E will have a greater optical density (used as an 
indicator of growth), regardless of LPS challenge, than the cells in all the 
other treatments. 
1. Expected Results: The cells in the 50 µM zinc/50 µM vitamin E 
treatment will have a greater amount of growth than the cells in 
the control treatment (0 µM zinc/0 µM vitamin E) regardless of 
LPS challenge. 
2. Expected Results: The cells in the 50 µM zinc/50 µM vitamin E 
treatment will have a greater amount of growth than the cells in 
the 50 µM zinc/0 µM vitamin E and the 0 µM zinc/50 µM 
vitamin E treatments regardless of LPS challenge. 
B. Hypothesis: The cells in the highest LPS challenge (1.0 µg LPS/mL) will 
have the greatest optical density.    
1. Expected Results: The cells challenged with 1.0 and 0.1 LPS µg 
LPS/mL will produce a greater optical density as compared to 
those cells not challenged with LPS. 
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2. Expected Results: The cells challenged with 1.0 µg LPS/mL will 
produce a greater optical density as compared to the cells 
challenged with 0.1 µg LPS/mL.    
C. Hypothesis: The cells supplemented with the combination of 50 µM zinc 
and 50 µM vitamin E will produce less nitric oxide when challenged with 
LPS than the cells in all the other treatments, regardless of concentration 
of LPS challenge.   
1. Expected Results: The cells in the 0 µM zinc/50 µM vitamin E 
treatment will produce less nitric oxide than the cells in the 
control treatment (0 µM zinc/0 µM vitamin E) regardless of 
concentration of LPS challenge. 
2. Expected Results: The cells in the 50 µM zinc/0 µM vitamin E 
treatment will produce less nitric oxide than the cells in the 
control treatment (0 µM zinc/0 µM vitamin E) regardless of 
concentration of LPS challenge. 
3. Expected Results: The cells in the 50 µM zinc/50 µM vitamin E 
treatment will produce less nitric oxide than the cells in the 50 
µM zinc/0 µM vitamin E and 0 µM zinc/50 µM vitamin E 
treatments regardless of concentration of LPS challenge.   
D. Hypothesis: The cells with the greatest LPS concentration (1.0 µg 
LPS/mL) will produce the greatest amount of nitric oxide regardless of 
treatment. 
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1. Expected Results: The cells challenged with 1.0 and 0.1 µg 
LPS/mL will produce more nitric oxide than those not challenged 
(0 µg LPS/mL). 
E. Hypothesis: The cells in the 50 µM zinc and 50 µM vitamin E treatment 
will produce less PGE2 than the cells in all the other treatments, regardless 
of concentration of LPS challenge. 
1. Expected Results: The cells in the 50 µM vitamin E treatment 
will produce less PGE2 than the cells in the control treatment (0 
µM zinc with 0 µM vitamin E). 
2. Expected Results: The cells in the 50 µM zinc treatment will 
produce less PGE2 than the cells in the control treatment (0 µM 
zinc with 0 µM vitamin E). 
F. Hypothesis: The cells challenged with the greatest amount of LPS (1.0 µg 
LPS/mL) will produce the greatest amount of PGE2.   
1. Expected Results: The cells challenged with LPS (1.0 and 0.1 µg 
LPS/mL) will produce a greater amount of PGE2 than the cells 
not challenged with LPS. 
G. Hypothesis: The cells in the 50 µM zinc and 50 µM vitamin E treatment 
will produce less TNF-α than the cells in all the other treatments. 
1. Expected Results: The cells in the 0 µM zinc/50 µM vitamin E 
treatment will produce less TNF-α than the cells in the control 
treatment (0 µM zinc/0 µM vitamin E). 
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2. Expected Results: The cells in the 50 µM zinc/0 µM vitamin E 
treatment will produce less TNF-α than the cells in the control 
treatment (0 µM zinc with 0 µM vitamin E). 
H. Hypothesis: The cells challenged with the greatest amount of LPS (1.0 µg 
LPS/mL) will produce the greatest amount of TNF-α.   
1. Expected Results: The cells challenged with LPS (0.1 and 1.0 µg 
LPS/mL) will produce a greater amount of TNF-α than the cells 
not challenged with LPS. 
I. Hypothesis: The cells in the 50 µM zinc and 50 µM vitamin E treatment 
will produce a greater amount of IL-10 than the cells in all the other 
treatments. 
1. Expected Results: The cells in the 0 µM zinc/50 µM vitamin E 
treatment will produce a greater amount of IL-10 than the cells in 
the control treatment (0 µM zinc/0 µM vitamin E). 
2. Expected Results: The cells in the 50 µM zinc/0 µM vitamin E 
treatment will produce a greater amount of IL-10 than the cells in 
the control treatment (0 µM zinc/0 µM vitamin E). 
J. Hypothesis: The cells challenged with the greatest amount of LPS (1.0 µg 
LPS/mL) will produce the greatest amount of IL-10.   
1. Expected Results: The cells challenged with LPS (0.1 and 1.0 µg 
LPS/mL) will produce a greater amount of IL-10 than the cells 







 The mouse monocyte/macrophage cell line (RAW 264.7) was purchased from 
ATCC (lot no. 1963180), at passage number 39.  This cell line was chosen because it 
does not produce nitric oxide upon treatment of interferon-α alone, but requires 
lipopolysaccharide (LPS) for full activation (ATCC 2001).  Thus, the cells are more 
similar to normal mouse macrophages (ATCC 2001).  The cells were thawed in a 37°C 
water bath for two minutes, and then placed in a T-75 flask with 11 mL of complete 
medium.  The complete medium (cDMEM) was Dulbelcco’s Moderate Eagle Medium 
(DMEM with phenol red; Sigma Chemical Co. Catalog no. D5523, St. Louis, MO) with 
10% fetal calf serum (Gibco Catalog no. 16000-044, Lot no. 1108708), and 0.5% 
Penicillin/Streptomycin (Sigma Chemical Co, St. Louis, MO).  The cells were counted to 
determine viability and cell counts were completed using trypan blue exclusion (0.4% 
Trypan Blue Solution) and a hemacytometer.  Cells were incubated with cDMEM in a 
humidified incubator at 37°C with 5% CO2/95% air.     
 The medium was changed every two to three days, and cells were subcultured 
upon reaching 80-90% confluence.  After the fifth subculture, the cells were frozen at a 
density of 1.0 x 106 cells/mL with cDMEM and 5% dimethyl sulfoxide (DMSO).  
Cryogenic vials were prepared by pipetting 50 µL of sterile dimethyl-sulfoxide into each 
one, and then adding 950 µL of cells.  The cryogenic vials were frozen at -20°C for four 
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hours, placed in a -80°C freezer overnight, and then transferred to liquid nitrogen for 
long-term storage.   All experiments were performed using these frozen cell aliquots.   
Media Analysis 
 Media was analyzed for zinc concentrations using the Perkin-Elmer 5100 PC 
Atomic Absorption Spectophotometer with AA Winlab Analyst software.    
Determination of the Optimal Cell Density 
Experimental Design.  In order to determine the optimal cell density to use for the main 
experiments, a growth experiment with a variety of cell densities was conducted.  The 
basis on which cell density was determined to be optimal for the subsequent experiments 
was the proliferation of the cells.  It was desired to have the cells proliferate as much as 
possible without surpassing the measurement protocols.  These cell densities included: 3 
x 103 cells/well, 6 x 103 cells/well, 1 x 104 cells/well, and 5 x 104 cells/well in a 96-well 
Tissue culture treated flat bottomed well plate with lid.  Two replications were 
completed, one replication had six wells per cell seeding density and the second 
replication had eight wells per seeding density, for a total of fourteen wells per cell 
density at each time point (24, 48, and 72 hours).   
Sample Analyses.  The cells were thawed from stock vials by placing 4 mL of cDMEM in 
a T-25 tissue culture flask and adding the cells from the vial after they had been thawed 
for 2 minutes in a 37°C water bath.  The flask was incubated overnight in a humidified 
incubator at 37°C with 5% CO2/95% air, and then 4 mL of spent medium was removed 
and replaced with new cDMEM.  The flask was placed back into the humidified 
incubator for forty-eight additional hours, after which, the cells were sub-cultured into 
two T-25 flasks following the previously described method.   
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For the experiment, the cells were plated into 96-well tissue culture plates at the 
different cell densities.  After 24, 48 or 72 hours of growth, the plates were removed from 
the incubator, the spent medium removed and replaced with fresh cDMEM.  Growth was 
measured using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide, Sigma cat. No. M2128) assay, which determines the amount of viable cells in 
each well of the plate.   The MTT is cleaved by the living cells to produce purple 
formazan crystals.   Therefore, only viable cells are measured (Mosmann et al., 1983).   
To perform the MTT assay, 50 µL of Hank’s Balanced Salt Solution (HBSS) with 
5 mg/mL MTT was added to each of the wells and the plates placed back into the 
incubators.  After 4 h of incubation time, the plates were removed from the incubator, and 
the MTT solution was removed from each well by aspiration.  To each well was then 
added 200 µL of dimethyl-sulfoxide and 50 µL of Sorenson’s Glycine buffer (0.1 M 
glycine, 0.1 M NaCl at a pH of 10.5- adjusted with 1 M NaOH if necessary).  The 
number of viable cells or growth was measured by determining the amount of formazan 
crystal formation using the BioTek ELx808 plate-reader and KCJunior software  
(v1.31.2) at a wavelength of 570 nm. This procedure was based on that previously 
described by Mosmann (1983).    
Determination of the Optimal Zinc Supplementation 
Experimental Design.  In order to determine the optimal zinc concentration to use in 
subsequent experiments, five different concentrations of zinc-supplemented medium 
were used.  These concentrations included: 0, 10, 50, 100 and 500 µM Zinc in cDMEM.  
These concentrations were based upon previous research (Driessen et al., 1995 & Abou-
Mohamed et al., 1998).  In this experiment, four replications were completed each with 
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six wells per treatment for a total of 24 wells per treatment at each time point.  Optimal 
zinc concentration was based on how well the cells proliferated in response to the 
different zinc concentrations; the greater the amount of proliferation, the more optimal 
the zinc concentration.       
Sample Analyses.  The cells were started following the same method used in 
determination of optimal cell density.  In order to test for cell growth in response to the 
different zinc concentrations, a 96-well plate was plated with a cell density of 1.0 x 
104cells/well (as determined in the previous experiement) with 200 µL of appropriate 
medium (0, 10, 50, 100, or 500 µM supplemental zinc).  The zinc media was prepared by 
adding zinc sulfate (Sigma Chemical Co, St. Louis, MO) to cDMEM to prepare a stock 
solution of 1 mM zinc, filter sterilizing with a Millex-GV Durapore syringe driven filter 
(0.22µM) and then preparing the working dilutions with cDMEM.  The plates were 
incubated in a humidified incubator at 37°C with 5% CO2/95% air for 24, 48 or 72 hours.  
The plates were removed from the incubator, and the MTT procedure previously 
described was used to determine cell growth.   
Determination of the Optimal Vitamin E Supplementation 
Experimental Design.  In order to determine the optimal vitamin E concentrations to use, 
four concentrations of vitamin E-supplemented medium were used.  These concentrations 
included: 0, 25, 50, and 100 µM vitamin E levels with the cDMEM.  These 
concentrations were based upon previous research (Visioli et al., 2000).  In this 
experiment, two replications were done with six wells used per treatment for a total of 
twelve wells per treatment at each time point.  Optimal vitamin E concentration was 
based on how well the cells proliferated in response to the different vitamin E 
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concentrations; the greater the amount of proliferation, the more optimal the vitamin E 
concentration.       
Sample Analyses.  The cells were started following the same method used in the previous 
experiments.  The vitamin E medium was prepared by diluting D-α-tocopherol acetate 
(Sigma Chemical Co, St. Louis, MO, cat no. T1157) with 95% ethanol to make a stock 
solution.  To prepare the working dilutions (0, 25, 50, or 100 µM supplemented vitamin E 
as D-α-tocopherol and ethanol control), the appropriate amount of stock solution needed 
for each working dilution was placed into a 5 mL conical tube with an appropriate 
amount of fetal bovine serum (FBS).  The tube was incubated for 15 min, vortexed after 
every 5 min and replaced in the incubator.  Following the 15 min incubation, the 
appropriate amount of FBS, DMEM, and penicillin/streptomycin were added.  By using 
this method, only 0.0945% of the media added to each well was 95% ethanol meaning 
less than 0.02 µM of the 200 µM media added to each cell was 95% ethanol, the 
remainder was medium, FBS or streptomycin.  By using doses at this level, an affect of 
ethanol on the cell functions should not be seen since it is such a small amount compared 
to the whole.       
In order to test for cell growth in response to the different vitamin E 
concentrations, a 96-well plate was plated with a cell density of 1.0 x 104cells/well with 
200 µL of appropriate media (0, 25, 50, or 100 µM supplemented vitamin E as α-
tocopherol and ethanol control), and placed into a humidified incubator at 37°C with 5% 
CO2/95% air.  After 24 and 48 hours of growth, the plates were removed from the 
incubator, and the MTT assay previously described was used to determine growth.  The 
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72 hour time point was not used since it was shown in the previous experiments that the 
protocol limitations were surpassed at this time point.     
Determination of the Optimal Lipopolysaccharide Challenge 
Experimental Design.  A complete block design with a 2 x 6 factorial arrangement of 
treatments was used for this study.  To determine the appropriate kind of LPS to use, E. 
Coli 055:B5 and E. Coli 0111:B4 strains (Sigma Chemical Co.) were used.  In order to 
determine the appropriate LPS concentrations to use, six different concentrations of LPS 
medium were used.  These concentrations included: 0, 0.1, 1.0, 10, 50, and 100 µg 
LPS/mL media (DMEM with 10% FBS without penicillin/streptomycin).  These levels 
were based upon previous research (Driessen et al., 1995; Jiang et al., 2000; & Abou-
Mohamed et al., 1998).  In this experiment, five replications were completed.  The 96-
well plates contained six wells per treatment (except for the last replication which 
contained three wells per treatment), whereas the 24-well plates contained two wells per 
treatment.  The basis on which LPS concentration and strain were optimal, was based on 
how well the cells proliferated with a particular LPS concentration and strain, and how 
much nitric oxide the cells produced in response to the LPS concentration and strain.  The 
more the cells proliferated and produced nitric oxide, the more desirable, or optimal, the 
strain and concentration as this would better allow the determination of potential changes 
by zinc and vitamin E in the subsequent experiment. 
Sample Analyses.  In order to determine cytotoxicity, the cells were thawed from our 
stock cells by following the method previously described.  The cells were plated on a 96-
well plate at a cell density of 1.0 x 104 cells/well with 200 µL of cDMEM added to each 
well.  After 24 h of growth, the spent medium was removed, and the LPS medium added 
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to each well.  The plates were then incubated for an additional 12, 24, 48, or 72 hours, 
after which they were removed from the incubator, and the MTT assay as previously 
described was performed.    
In addition to the 96-well plates, 24-well plates were plated at a cell density of 
6.66 x 104 cells/well with 1 mL of cDMEM added to each well. The seeding density of 
6.66 x 104 cells/well in the 24-well plates was equivalent to the 1.0 x 104 cells/well 
density in the 96-well plate since the 24-well plate has larger well sizes.  The 24-well 
plates were treated in the same manner as the 96-well plates, except after the 12, 24, 48, 
and 72 hour incubation, the Griess assay (Promega, Madison, WI) was completed.  The 
Griess Assay was done following manufacturer’s directions in order to determine nitric 
oxide production.  The Griess assay measures the amount of NO2- (a product of nitric 
oxide breakdown) in the sample by using sulfanilamide and N-1mapthylethylenediamine 
dihydrocholoride to produce a purple color that can measured at 520 nm using a Biotek 
plate reader and KCJunior software (Promega corporation, 1995).      
Determination of the Optimal Combination of Vitamin E and Zinc 
Experimental Design.  A randomized block design with a 2 x 4 factorial arrangement of 
treatments was used for this study.  The combinations included all of the combinations of 
0, 25, 50, and 100 µM vitamin E concentrations with 0, 10, 50 and 100 µM Zinc 
concentrations in cDMEM (without phenol red, Sigma product number D2902), and 
included an ethanol control.  Two replications of this experiment were completed with 
four wells of each treatment per relplication for a total of eight wells per treatment at each 
time point.  After observing the results from these replications, an additional replication 
of this experiment was completed using only the combinations of 0 and 50 µM zinc 
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concentrations with 0 and 50 µM vitamin E concentrations to see if these were the 
concentrations that were desired.  This additional replication had six wells per treatment 
at each time point.   The optimal combination of zinc and vitamin E concentrations was 
based on how well the cells proliferated in response to the different combinations; the 
greater the amount of proliferation, the more optimal the combination of those 
concentrations.       
Sample Analyses.  The cells were thawed following the method previously described, 
using cDMEM that did not contain phenol red since the phenol red might decrease the 
test reliability in this and further experiments.   After the cells were allowed to grow for 
three days, they were subcultured following the method previously described.  The cells 
were plated in 96-well plates at a cell density of 1.0 x 104 cells /well with 200 µL of 
appropriate zinc and vitamin E supplemented medium.  The medium was prepared 
following the methods previously described for the vitamin E medium, and adding the 
appropriate amount of zinc stock in place of the same amount of cDMEM.   
The plates and T-25 flasks were then placed into a humidified incubator at 37°C 
with 5% carbon dioxide/95% air, and allowed to grow for 24 or 48 additional hours.  
After these times were completed, the MTT assay (as previously described) was 
performed to measure growth.   
Determination of the Influence of Vitamin E and Zinc on Mouse Macrophage 
Response to a Lipopolysaccharide Challenge 
 
Experimental Design.  A complete block design with a 6 x 3 factorial arrangement of 
treatments was used for this study.  The treatments consisted of different concentrations 
of zinc with vitamin E: 0 or 50 µM zinc and/or vitamin E.  Indomethacin is a commonly 
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used non-steroidal anti-inflammatory drug that helps to decrease prostaglandin 
production (Basini, 2001); therefore, indomethacin (5 or 10 µM) was added as a positive 
control.  The cells were plated with these different mediums, then were allowed to grow 
for 24 hours.  After 24 hours, the zinc and/or vitamin E supplemented cells were 
incubated with three different concentrations of lipopolysaccharide (E. Coli 055:B5): 0 
µg/mL, 0.1 µg/mL, and 1.0 µg/mL.  These concentrations were based upon the results of 
the previous experiments.     
Sample Analyses.  Cells were started in the same manner as previously described.  
Measurement of Growth.  Growth and cytotoxicity were determined by plating 96-well 
plates at a cell density of 1.0 x 104 with 200 µL of appropriate medium (0 and/or 50 µM 
zinc and 0 and/or 50 µM vitamin E, ethanol control, and 5 µM or 10 µM indomethacin).  
After 24 h of incubation with the appropriate medium, the medium was removed and 
replaced with 200 µL of the appropriate treated medium containing the LPS 
concentrations.  Four hours prior to the end of the incubation time with LPS (24 or 48 h), 
the plates were removed from the incubator.  The spent medium was removed and 
replaced with 200 µL fresh medium of the same kind (containing both the LPS and the 
treatment), and 50 µL of Hank’s Balanced Salt Solution (HBSS) with 5 mg/mL MTT 
added to each of the wells, and the plates placed back into the incubators.  The MTT 
assay as previously described was then performed.  This was replicated two times with 
fours wells per treatment used in each replication. 
Production of Nitric Oxide.   To determine the effects of zinc and vitamin E on nitric 
oxide (NO), PGE2, Il-10, and TNF-α, the cells were plated in 24-well plates at a cell 
density of 6.66 x 104 cells/well with 1 mL of the appropriate media (0 and/or 50 µM zinc 
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and 0 and/or 50 µM vitamin E, ethanol control, and 5 µM or 10 µM indomethacin).  The 
media was prepared following the method previously described, with the exception of not 
using penicillian/streptomycin, which was not used since it might decrease the 
macrophage’s reaction to the LPS challenge. 
After 24 h of incubation with the zinc and vitamin E medium, the LPS treatments 
were added to the appropriate wells.  After 24 or 48 h of incubation with LPS, the plates 
were removed from the incubator, and placed on ice.  The Griess assay (Promega, 
Madison, WI) was then performed as previously described.  Two replications of this with 
two wells per treatment were performed.     
Measurement of Cytokines.  After an aliquot of spent medium had been removed for 
nitric oxide measurement, the plates were centrifuged at 4ºC for 5 min at 1000 rpms, and 
supernatants collected, and 200 µL alliquoted into cryovials, and stored at -80°C until 
used for cytokine measurements.  Two replications were completed for 24 h and three 
replications were completed for 48 h, each with two wells per treatment.  To determine 
TNF-α production, the supernatants were thawed, vortexed, and analyzed using the TNF-
α enzyme-linked immunosorbent assay kit by BD Pharmingen (Catalog No. 555268).  
Interleukin-10 production was determined in this same manner using BD Biosciences’s 
BD OptEIA Mouse IL-10 Set (Catalog No. 555252), as was prostaglandin-E2 production 
using Amersham Biosciences Prostaglandin E2 Biotrak Enzymeimmunoassay (EIA) 
system.    
Statistical Analysis 
Data was analyzed using SAS (version 8.01, Cary, North Carolina, USA).  A mixed 
model was used with the random effects being the replication of each experiment.  Least 
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square means and differences of least square means were determined then adjusted using 
Tukey’s multiple-comparison to determine treatment effects.  Interactions between LPS 
concentrations and treatments were compared to each other as well as compared together 
against the main effects.  Significance was considered at p < 0.05.  Data is shown as 






Determination of the Optimal Cell Density 
 
 In order to determine the optimal seeding density of the macrophages, we used a 
variety of cell densities and measured the number of viable macrophages (optical density) 
by MTT assay after 24, 48 and 72 hours of growth.  The optical density was used as a 
measure of growth of the macrophages in these experiments.  After twenty four hours, the 
optical density (O.D.) or growth of the macrophages seeded at 5x104 cells/well (2.85 ± 
0.033) was greater (p<0.05) than the growth of the macrophages seeded at 1 x 104 
cells/well, 3 x 103 cells/well or 6 x 103 cells/well (0.85 ± 0.027, 0.33 ± 0.022 and 0.44 ± 
0.027 respectively).  It was also shown that the growth of the macrophages seeded at 1 x 
104 cells/well was greater than (p<0.05) the growth of the macrophages seeded at 3 x 103 
cells/well and 6 x 103 cells/well; however, the growth of the macrophages seeded at 3 x 
103 cells/well and 6 x 103 cells/well were similar (p>0.05).  After 48 hours, the 
macrophages seeded at 5x104 cells/well (3.80 ± 0.085) had a greater amount of growth 
(p<0.05) than the other cell densities.  The macrophages seeded at 1 x 104 cells/well (1.05 
± 0.069) had a greater amount of growth (p<0.05) than macrophages seeded at 3 x 103 
cells/well and 6 x 103 cells/well (0.25 ± 0.044 and 0.43 ± 0.054 respectively); however, 
the growth of the macrophages seeded at 3 x 103 cells/well and 6 x 103 cells/well were 
still similar (p>0.05).  After 72 hours of growth, the macrophages seeded at 5x104 
cells/well did not have a growth that was measurable due to the limitations of the MTT 
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assay, and the KCJunior software.  The KCJunior software can only measure optical 
densities of 4.0 or less in this assay, and the optical density of this seeding density at 72 
hours was greater than 4.0.  However, the growth was determined for the other seeding 
densities.  These results revealed that the growth of the macrophages at a seeding density 
of 1 x 104 cells/well (2.26 ± 0.201) was greater than (p<0.05) the growth of the 
macrophages at a seeding of 3 x 103 cells/well (0.93 ± 0.06) and 6 x 103 cells/well (1.49 ± 
0.10); also at this time point, the macrophages seeded at 6 x 103 cells/well had a greater 
amount of growth than (p<0.05) the macrophages seeded at 3 x 103 cells/well.   
 
Determination of the Optimal Zinc Supplementation 
 
 At 24 hours, the O. D. or growth was unaffected (p>0.05) by zinc 
supplementation at levels less than or equal to100 µM (Figure 1).  Supplementation with 
500 µM zinc decreased (p<0.05) the growth compared with macrophages supplemented 
with 100 µM or less of zinc.  At 48 hours, the growth of macrophages supplemented with 
500 µM zinc was less than (p<0.05) that of the macrophages supplemented with 100 µM 
or less of zinc.  Also, at this time point, the growth with 10 µM and 50 µM zinc was 
greater than (p<0.05) with 100 µM zinc (Figure 1).  After 72 hours, the macrophages in 
the 0 µM, 10 µM, 50 µM, and 100 µM zinc supplemented medium had growths greater 
(p<0.05) than the macrophages in the 500 µM zinc supplemented medium, but were 
similar (p>0.05) to each other (Figure 1). 
Determination of the Optimal Vitamin E Supplementation 
At 24 hours, the O. D. (or growth) was unaffected (p>0.05) by vitamin E 
supplementation (Figure 2).  After 48 hours, the growth of the macrophages in the 0 µM, 
25 µM, and 100 µM vitamin E supplemented medium was less than (p<0.05) the growth 
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of the macrophages in the 50 µM vitamin E supplemented medium; however, the growth 
in these concentrations of vitamin E supplementation was similar (p>0.05) (Figure 2).   
Determination of the Optimal Lipopolysaccharide Challenge 
Number of Viable Cells 
A significant (p<0.05) three way interaction was observed among strain, 
concentration and time for the optical density or number of viable cells (Figure 3).  
Therefore, the data was analyzed for a two-way interaction between time and 
concentration within each strain of LPS.   
E. Coli 055:B5.  With the E. Coli 055:B5, the number of viable macrophages, in all LPS 
concentrations were similar (p>0.05) after 12 hours of LPS challenge (Figure 3A).  After 
24 hours, the number of viable macrophages in 0 and 0.1 µg LPS/mL media was greater 
than in 100 µg LPS/mL media (p<0.05).  The number of viable macrophages in 1.0, 10, 
50, and 100 µg LPS/mL media was similar (p>0.05), as was the number in 0 and 0.1 µg 
LPS/mL media (p>0.05) (Figure 3A).  When the macrophages had been challenged for 
48 hours with the E. Coli 055:B5, the number of viable macrophages in 0, 0.1, and 1.0 µg 
LPS/mL media was greater than (p<0.05) that of the macrophages in 5, 10, 50 and 100 µg 
LPS/mL media.  It was also determined the macrophages with 0, 0.1, and 1.0 µg LPS/mL 
media all had similar (p>0.05) numbers of viable macrophages.  The number of viable 
macrophages with 5, 10, 50 and 100 µg LPS/mL media were also similar (p>0.05).  
(Figure 3A).  After 72 hours of the E. Coli 055:B5 challenge, the number of viable 
macrophages in 5, 10, and 100 µg LPS/mL media was less than (p<0.05) that of 
macrophages with 0, 0.1, and 1.0 µg LPS/mL media.  The macrophages in 0, 0.1, and 1.0 
µg LPS/mL media wells had a cell viability number that was similar to each other 
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(p>0.05), as did the macrophages with 5, 10, 50 and 100 µg LPS/mL media to each other 
(p>0.05).  The number of viable macrophages in 50 µg LPS/mL media was similar 
(p>0.05) to that of the macrophages in the 1.0, 5, 10, and 100 µg LPS/mL media. (Figure 
3A).    
E. Coli 0111:B4.  After 12 hours of incubation with LPS from the E. Coli 0111:B4 strain, 
the macrophages challenged with 0 and 0.1 µg LPS/mL media had a greater (p<0.05) 
number of viable macrophages than those challenged with 50 and 100 µg LPS/mL media, 
but were similar (p>0.05) to each other (Figure 3B).  After 24 hours of the challenge, the 
number of viable macrophages in each well was similar (p>0.05) for 0 and 0.1 µg 
LPS/mL media, but was greater (p<0.05) in 0 µg LPS/mL media than in 5, 50, and 100 
µg LPS/mL media.  The macrophages with 0.1 µg LPS/mL media had a similar (p>0.05) 
number as all the other concentrations except for 100 µg LPS/mL media; which had a 
lesser number (p<0.05) of viable macrophages than with 0.1 µg LPS/mL media.  The 
other numbers were similar (p>0.05) (Figure 3B).  After 48 hours of challenge, the 
macrophages in 0, 0.1, and 1.0 µg LPS/mL media had a greater (p<0.05) number of 
viable macrophages than the macrophages in 5, 10, 50 and 100 µg LPS/mL media; 
however, the macrophages in 0, 0.1 and 1.0 µg LPS/mL media had numbers similar 
(p>0.05) to each other, as did (p>0.05) the macrophages in 5, 10, 50 and 100 µg LPS/mL 
media.  (Figure 3B).  After 72 hours of growth with the E. Coli 0111:B4, the number of 
viable macrophages in the 0 µg LPS/mL media was not able to be determined due to 
protocol limitations, the growth was too great.  The number of viable macrophages in 0.1 
and 1 µg LPS/mL media were similar (p>0.05) to each other, however, their numbers 
 51
were greater (p<0.05) than those of the macrophages challenged with 5, 10, 50 and 100 
µg LPS/mL media.  The macrophages in 5 µg LPS/mL media also had a greater (p<0.05) 
number of viable macrophages than the macrophages in 50 and 100 µg LPS/mL media, 
but was similar (p>0.05) to the number in the 10 µg LPS/mL media.  (Figure 3B).    
Production of Nitric Oxide.  The results of the Griess assay, which was used to determine 
nitric oxide levels produced by the macrophages in response to the LPS challenge, did 
not reveal a significant (p>0.05) three way interaction (strain, time and concentration) 
(Figure 4).  However, there were significant two way interactions between strain and 
time, time and concentration, and strain and concentration (data for interactions not 
shown; refer to Figure 4 for data shown by strain, time and concentration).   
 When the data was analyzed for strain and concentration, macrophages with 0 and 
100 µg LPS/mL media from the E. Coli 055:B5 strain produced less (p<0.05) nitric oxide 
than the ones with 0.1, 1.0, 5 and 10 µg LPS/mL media.  The macrophages with the 0 µg 
LPS/mL media from E. Coli 0111:B4, produced less (p<0.05) nitric oxide than those with 
0.1, 1.0, 5, 10 and 100 µg LPS/mL media.  Also, the macrophages with 100 µg LPS/mL 
media from E. Coli 0111:B4 produced less (p<0.05) nitric oxide than the macrophages 
with 0.1, 1.0, 5 and 10 µg LPS/mL media.   
 When the data was analyzed for strain and time, it was shown that macrophages 
with the LPS from the E. Coli 055:B5 strain produced less (p<0.05) nitric oxide at zero 
and 12 hours than at 24, 48 and 72 hours.  At 24 hours, less (p<0.05) nitric oxide was 
produced than at 48 and 72 hours also.  These macrophages also produced less (p<0.05) 
nitric oxide at 48 hours than at 72 hours.  The results were the same in the macrophages 
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with LPS from the E. Coli 0111:B4, except no difference (p>0.05) was seen between 
zero, 12 or 24 hours.   
 The two way interaction of time and concentration was also analyzed.  There were 
no differences (p>0.05) found in nitric oxide produced by any LPS concentration at zero, 
12, or 24 hours.  After 48 hours, the macrophages challenged with 1.0 µg LPS/mL media 
produced greater (p<0.05) amounts of nitric oxide than those challenged with 0 and 100 
µg LPS/mL media, but the same (p>0.05) as the other concentrations.  It was also found 
at this time, the macrophages stimulated with 0 µg LPS/mL media produced less (p<0.05) 
nitric oxide than those stimulated with 0.1, 1.0, 5 and 10 µg LPS/mL media, but similar 
amounts to those macrophages stimulated with 100 µg LPS/mL media.    
After 72 hours, the macrophages stimulated with 0 µg LPS/mL media produced 
less (p<0.05) nitric oxide than those stimulated with 0.1, 1.0, 5, 10 and 100 µg LPS/mL 
media.  The macrophages with 0.1 µg LPS/mL media produced a greater amount 
(p<0.05) of nitric oxide than those with 0, 5, 10 and 100 µg LPS/mL media, as did those 
with 1.0 µg LPS/mL media.  The macrophages stimulated with 5 and 10 µg LPS/mL 
media produced a greater amount (p<0.05) of nitric oxide than those with 0 and 100 µg 
LPS/mL media, however, they produced similar amounts (p>0.05) as each other.            
Determination of the Optimal Combination of Vitamin E and Zinc 
 In order to determine the optimal combination of vitamin E and zinc to use in the 
experiments with LPS, all the possible combinations of four different concentrations of 
zinc (0, 10, 50 and 100 µM Zinc) and four different concentrations of vitamin E 
supplementation (0, 25, 50, and 100 µM vitamin E) were used, along with an ethanol 
control.  Macrophages were grown in each of the combinations of the supplemented 
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media, and growth was assessed after 24 and 48 hours of growth as done in previous 
experiments.  When the data was analyzed, there was a significant (p<0.05) interaction 
among time, vitamin E supplementation and zinc supplementation; therefore, the data 
was analyzed within each time (Table 1).  As time progressed, stronger differences were 
detected among the vitamin E and zinc treatments (Table 1).   
 After 24 hours of supplementation, there was not a significant interaction between  
zinc and vitamin E supplementation (Table 2), however there was a trend (p=0.074).  The 
main effect of vitamin E was significant (p<0.05).  After 24 hours, the macrophages 
grown in the 0 µM vitamin E media had a greater (p<0.05) amount of growth than the 
macrophages grown in the 100 µM vitamin E media (Figure 5).  Growth was not different 
(p>0.05) among 25, 50, or 100 µM vitamin E, nor was it different among 0, 25 or 50 µM 
vitamin E.   
 After 48 hours of supplementation, there was a significant (p<0.05) interaction 
between vitamin E and zinc (Table 1).  When the data was analyzed for vitamin E effects 
within each zinc concentration (Table 3), it was found that macrophages with media that 
contained 0 µM zinc and 0 µM vitamin E had a lower (p<0.05) amount of growth than 
the macrophages in the 0 µM zinc with 50 µM vitamin E.  The opposite was seen with the 
10 µM zinc supplementation (Table 3), the 10 µM zinc with 0 µM vitamin E had a greater 
(p<0.05) amount of growth than the macrophages in the 10 µM zinc with 25 µM or 50 
µM vitamin E.  At the 10 µM zinc concentration, it was also shown that macrophages in 
the 50 µM vitamin E had a lesser (p<0.05) amount of growth than the macrophages in the 
100 µM vitamin E.  Macrophages grown in the 50 µM zinc media (Table 3) with either 0 
or 100 µM vitamin E had a greater (p<0.05) amount of growth than the macrophages in 
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the 50 µM zinc media with the 25 or 50 µM vitamin E media.  There were no significant 
(p>0.05) differences with 100 µM zinc and any of the vitamin E concentrations (Table 3).    
Determination of the Influence of Vitamin E and Zinc on Mouse Macrophage 
Response to a Lipopolysaccharide Challenge 
Optical Density (Growth).  There was a significant (p<0.05) three-way interaction among 
media treatment (zinc and/or vitamin E), time and LPS concentration; therefore, the data 
was analyzed within time for an interactive effect between treatment and LPS (Figure 6).   
 After 24 hours, the growth was similar (p>0.05) across treatments (Figure 6A).  
After 48 hours differences were observed with treatment and LPS concentration.  The 
macrophages that were subjected to 0 µg LPS/mL media had similar (p>0.05) growth 
across all treatments.  For macrophages challenged with 0.1 µg LPS/mL media, the 
growth of the macrophages treated with 10 µM Indomethachin was less than (p<0.05) 
that of the macrophages in the other treatments.  The macrophages that were challenged 
with 1.0 µg LPS/mL media and incubated in the 0 µM zinc/50 µM vitamin E 
supplemented media had a greater (p<0.05) amount of growth than those in both the 10 
µM Indomethachin media and the 50 µM zinc/0 µM vitamin E supplemented media.  
Also the macrophages challenged with 1.0 µg LPS/mL media that were grown in the 0 
µM zinc/0 µM vitamin E supplemented media had a greater (p<0.05) amount of growth 
than that of the macrophages in the 50 µM zinc/0 µM vitamin E supplemented media.   
Production of Nitric Oxide.  In order to determine nitric oxide produced by macrophages 
in zinc and vitamin E supplemented medias, macrophages were challenged with different 
concentrations of LPS from E.Coli 055:B5 (0, 0.1, and 1.0 µg LPS/mL media).  There 
was not a significant (p>0.05) three way interaction (treatment, LPS concentration and 
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time) (Figure 7).  However, there were significant interactions between LPS 
concentration and time (p<0.05) (Figure 8) and treatment by LPS concentration (p<0.05) 
(Figure 9). 
 When the data was analyzed looking at LPS concentration by time, it was shown 
that at 24 hours, the macrophages in 0 µg LPS/mL media produced less (p<0.05) nitric 
oxide than macrophages in 1.0 µg LPS/mL.  At 48 hours, the macrophages in 0 µg 
LPS/mL media produced less (p<0.05) nitric oxide than macrophages in both 0.1 and 1.0 
µg LPS/mL media.   
 At 0.1 µg LPS/mL media, the macrophages in the 0 µM zinc/ethanol control 
supplemented media produced a greater (p<0.05) amount of nitric oxide than those in the 
0 µM zinc/50 µM vitamin E  and 50 µM zinc/50 µM vitamin E supplemented medias.  
However, the 0 µM zinc/ethanol control was not different (p>0.05) from 0 µM zinc/0 µM 
vitamin E.  With macrophages challenged with 1.0 µg LPS/mL media, the 0 µM 
zinc/ethanol control produced less (p<0.05) nitric oxide than the other treatments and 
indomethacin controls.  There were no differences (p>0.05) among the zinc/vitamin E 
treatments and indomethacin controls.   
Tumor Necrosis Factor-α (TNF-α).  Tumor necrosis factor-α was measured as an 
indicator of the inflammatory response following the LPS challenge.  No differences 
(p>0.05) were seen between treatment and LPS concentrations (Figure 10), but 
differences (p<0.05) among LPS concentrations  were seen.  The TNF-α produced by 
macrophages challenged with 0 µg LPS/mL media (14.96 ± 10.42 pg/mL) was less than 
(p<0.05) that produced by the macrophages challenged with 0.1 or 1.0 µg LPS/mL media 
(4783.19 ± 632.55 and 6036.56 ± 688.14 pg/mL respectively).  The macrophages 
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challenged with 0.1 or 1.0 µg LPS/mL media produced similar (p>0.05) amounts of TNF-
α.     
Interleukin-10.  Interleukin-10 (IL-10) an anti-inflammatory mediator was also measured.  
The results revealed no significant (p>0.05) difference in the interaction between 
treatment and LPS concentration (Figure 11).  The data was further analyzed looking for 
the main effects of treatment and LPS, which did reveal significant (p<0.05) effects of the 
IL-10 produced among treatments and among the LPS concentrations (p<0.05) (data not 
shown).   
 The treatment effects revealed the IL-10 produced by macrophages grown in the 5 
and 10 µg Indomethacin medias was greater than (p<0.05) that produced by macrophages 
in 50 µM zinc/50 µM vitamin E, 50 µM zinc/0 µM vitamin E, 0 µM zinc/50 µM vitamin 
E, and 0 µM zinc/ethanol control supplemented medias (data not shown).  The levels 
produced by the macrophages in the 5 and 10 µM Indomethacin medias were similar 
(p>0.05) to that produced by the macrophages in the 0 µM zinc/0 µM vitamin E 
supplemented media, as were the levels produced by the macrophages in the 50 µM 
zinc/50 µM vitamin E, 50 µM zinc/0 µM vitamin E, 0 µM zinc/50 µM vitamin E, and 0 
µM zinc/ethanol control supplemented medias (data not shown).   
Prostaglandin- E2 (PGE2).  Prostaglandin-E2 (PGE2) is another inflammatory mediator 
that is released by the macrophage in response to a LPS challenge.  The results revealed a 
trend (p=0.0802) for an interaction between treatment and LPS concentration (Figure 12).  
Significant main effects did exist among treatment (p<0.05), and LPS concentrations 
(p<0.05) (data not shown).   
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 When the data was analyzed for differences among treatments, it was shown that 
the macrophages in the 0 µM zinc/50 µM vitamin E treatment produced a greater 
(p<0.05) amount of PGE2 than the macrophages treated with 5 µM or 10 µM 
Indomethacin and challenged (refer to Figure 12).   
 When the data was analyzed for differences among LPS concentrations, the 
macrophages challenged with 1.0 µg LPS/mL media produced a greater (p<0.05) of IL-
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Figure 1.  Growth of macrophages in zinc supplemented medium.   
Values shown are means ± standard errors.   a,b,c Means within a time period without 
common letters are significantly different.  (p<0.05).   
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Figure 2.  Growth of macrophages in vitamin E supplemented medium.  Values shown 
are means ± standard errors.  a.b Means within a time period without common letters are 
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Figure 3.  Growth of macrophages in medium after challenge with lipopolysaccharide 
(LPS) from E. Coli 055:B5 (A) and E. Coli 0111:B4 (B).  Values shown are means ± 
standard errors.  a,b,c Means within a time period without common letters are significantly 
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B.  E. Coli  0111:B4 
 
Figure 4.  Nitric oxide produced by macrophages after challenge with lipopolysaccharide 
(LPS) from E. Coli 055:B5 (A) and E. Coli 0111:B4 (B).  Values are means ± standard 
errors.  The data is presented by strain; however, there was not a significant (p>0.05) 
three way interaction among strain, concentration and time. 
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Table 1.  P-values for the Growth of Macrophages in Vitamin E and Zinc  





Time x Zinc 0.0011 
Vitamin E 0.0001 
Time x Vitamin E 0.0002 
Zinc x Vitamin E <0.0001 
Time x Zinc x Vitamin E 0.0001 
  
By Time- 24 Hours  
Zinc 0.0822 
Vitamin E 0.0441 
Zinc x Vitamin E 0.0741 
  
By Time- 48 Hours  
Zinc 0.0091 
Vitamin E <0.0001 
Zinc x Vitamin E <0.0001 
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Table 2.  Growth of Macrophages in Vitamin E and Zinc Supplemented Medium  




(µM) Optical Density  
0 0 0.808 ± 0.034 
0 25 0.707 ± 0.018 
0 50 0.999 ± 0.101 
0 100 0.782 ± 0.054 
   
10 0 0.696 ± 0.023 
10 25 0.681 ± 0.042 
10 50 0.722 ± 0.036 
10 100 0.693 ± 0.046 
   
50 0 0.949 ± 0.070 
50 25 0.759 ± 0.040 
50 50 0.910 ± 0.076 
50 100 0.861 ± 0.040 
   
100 0 0.698 ± 0.054 
100 25 0.692 ± 0.027 
100 50 0.721 ± 0.040 
100 100 0.750 ± 0.028 
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Figure 5.  Growth of macrophages in vitamin E supplemented medium irrespective of 
zinc supplementation.  Values shown are means ± standard errors.  a.b Means without 
common letters are significantly different from each other (p<0.05).  
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Table 3.  Growth of Macrophages in Vitamin E and Zinc Supplemented Medium 




(µM) Optical Density  
0 0 1.973± 0.150b 
0 25 1.959 ± 0.184a,b 
0 50 2.331 ± 0.280a 
0 100 1.904 ± 0.093b 
   
10 0 2.194 ± 0.245a 
10 25 1.624 ± 0.097b,c 
10 50 1.392 ±0.062c 
10 100 2.009 ± 0.146a,b 
   
50 0 2.474 ± 0.237a 
50 25 1.268 ± 0.063b 
50 50 1.885 ± 0.184b 
50 100 1.955 ± 0.121a 
   
100 0 1.548 ± 0.078 
100 25 1.495 ± 0.174 
100 50 1.198 ± 0.076 
100 100 1.789 ± 0.273 
                                                 
1 Values are means ± standard errors. 
 
a,b,c Means within each zinc concentration that do not have common letters are 
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B.   48 Hours
 
Figure 6.  Growth of macrophages in vitamin E and zinc supplemented medium after 24 
(A) and 48 (B) hours of challenge with LPS from E. Coli 055:B5.  Values shown are 
means ± standard errors.  a,b,c Means within each E. Coli 055: B5 concentration without 
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Figure 7.  Nitric oxide produced by macrophages in zinc and vitamin E supplemented 
medium after 24 (A) and 48 (B) hours of challenge with LPS from E. Coli 055:B5.  































Figure 8.  Nitric oxide produced by macrophages in response to challenge with LPS from 
E. Coli 055:B5.  Values shown are means ± standard errors.  a,bMeans within each 
lipopolysaccharide concentration without common letters are significantly different 






















































Figure 9.  Nitric oxide produced by macrophages grown in zinc and vitamin E 
supplemented medium and challenged with LPS from E. Coli 055:B5.  Values shown are 
means ± standard errors.  a,bMeans within each E. Coli 055:B5 concentration without 



















































Figure 10.  Tumor necrosis factor alpha (TNF-α) produced by macrophages grown in 
vitamin E and zinc supplemented medium after challenge with LPS from E. Coli 055:B5.  






















































Figure 11.  Interleukin 10 (IL-10) produced by macrophages grown in zinc and vitamin E 
supplemented medium after challenge with LPS from E. Coli 055:B5.  Values shown are 























































Figure 12.  Prostaglandin E2 (PGE2) produced by macrophages in zinc and vitamin E 
supplemented medium after challenge with LPS from E. Coli 055:B5.  Values shown are 




DISCUSSION   
 
Determination of the Optimal Cell Density 
 
 In these experiments, optical density (O. D.) as determined by the MTT assay was 
used as an indicator of cell growth.  This experiment showed the greater the seeding 
density, the greater the growth after a certain incubation time.  The highest seeding 
density, 5 x 104 cells/well had the greatest amount of growth of all the seeding densities at 
24 and 48 hours; however, due to the high rate of growth, the O. D. was unable to be 
measured after 72 hours due to protocol limitations.  The protocol used was only able to 
measure up to an O. D. of 4.0, which was surpassed within 72 hours.  Because some of 
the experiments needed to be carried out to 72 hours, the high rate of growth made this 
seeding density undesirable for the subsequent experiments.   
 The 6 x 103 cells/well seeding density was not significantly greater than the 3 x 
103 cells/well density until after 72 hours of growth, which may be due to the lack of 
needed growth factors for replication due to the small seeding density and less cell to cell 
contact than the other seeding densities.  The seeding density of 1 x 104 cells/well had a 
greater amount of growth than 6 x 103 cells/well and 3 x 103 cells/well at 24, 48 and 72 
hours.  This seeding density also had a lesser growth than the 5 x 104 cells/well, and did 
not surpass the protocol limitations making it a favorable choice for the subsequent 
experiments.   
Determination of the Optimal Zinc Supplementation 
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 In this experiment, the optimal zinc supplementation of the cells was determined 
based on growth.  This experiment revealed that the growth of the cells in medium 
supplemented with 0 µM, 10 µM, 50 µM and 100 µM zinc was greater at all time points 
than the cells in the 500 µM zinc supplemented medium.  This suggests that at this zinc 
supplementation concentration, the zinc was toxic to the cells leading to the decline in 
growth.  Over supplementation with zinc was shown by Chandra (1984) to impair 
chemotaxis and neutrophil activity, so it also may impair the rate of growth of the 
macrophages.  Prasad (1978) indicated that humans given long-term zinc supplements 
became copper deficient, which could also be a factor in the present study.  Copper 
deficiency could lead to a decrease seen in growth, and future studies should assess 
whether or not copper deficiency is being induced in these cells.   
 After 48 hours of growth, the cells in the 100 µM zinc supplemented medium had 
a lesser amount of growth than the cells in the 10 µM and 50 µM zinc supplemented 
medium, but a similar amount to the cells in the 0 µM zinc supplemented medium 
suggesting a beneficial effect of the lower zinc concentrations on cell growth; however, 
this effect was not seen after 24 or 72 hours.   
Determination of the Optimal Vitamin E Supplementation 
 
 This experiment was performed to determine the optimal vitamin E 
supplementation based on the growth after 24 and 48 hours in the supplemented medium.  
This was used to determine what vitamin E supplementation concentrations should be 
used for subsequent experiments.  The growth of the cells in the 0 µM, 25 µM, 50 µM 
and 100 µM vitamin E supplemented media was not different after 24 hours, which 
indicates no cytotoxic or cell enhancing effects at these vitamin E levels and this time 
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point.  After an additional 24 hours of growth (48 hours total), growth in all the vitamin E 
supplementation concentrations was similar with the exception of the 50 µM vitamin E 
supplemented medium, which was greater than that of the others.  This indicates that this 
level of supplementation was beneficial to the cell, and thus enhanced the growth.  Sakai 
et al. (1997) showed that lymphocyte proliferation could be enhanced with vitamin E 
supplementation when stimulated with PHA and ConA, and Moriguchi (1998) showed 
that vitamin E supplementation led to an increase in T-cell differentiation that led to an 
increase in lymphocyte proliferation.  Combined with these studies, the results of the 
present study suggest an increase in macrophage growth as a result of vitamin E 
supplementation.  Perhaps vitamin E supplementation has a positive effect on growth of 
many different types of cells in the immune system since it had a positive effect on the 
growth of the macrophages in this study, and other studies (Moriguchi, 1998; Sakai et al., 
1997) have shown its positive effects on proliferation of other types of immune cells.  
There was no effect from the 100 µM vitamin E supplementation in the present study 
though, which could suggest that the enhancement is dose dependent and that the 100 µM 
vitamin E concentration is too much vitamin E to show a positive effect on cell growth.       
 
Determination of the Optimal Lipopolysaccharide Challenge 
 
 This experiment was performed not only to determine the optimal amount of 
lipopolysaccharide (LPS) to use in subsequent experiments, but to determine which strain 
of E. Coli, either 055:B5 or 0111:B4, to use the LPS from as well.  These two factors 
were determined by macrophage growth and nitric oxide produced by the macrophages.  
With E. Coli 055:B5 strain, the O. D. (i.e. number of viable cells) was similar at all time 
points (12, 24, 48 and 72 hours after challenge) for macrophages incubated with 0, 0.1 
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and 1.0 µg LPS/mL media.  Similar results were also seen with E. Coli 0111:B4; 
however, with this strain, the number of viable cells was not able to be determined at 0 
µg LPS/mL media at 72 hours due to protocol limitations since the O. D. was greater than 
the maximum measurable O. D.  The results also revealed that with LPS from both 
strains of E. Coli, after 48 hours of challenge, the number of viable cells in the  0, 0.1 and 
1.0 µg LPS/mL media concentrations was consistently higher than with LPS 
concentrations greater than or equal to 5 µg LPS/mL.  These results could suggest that 
the 0.1 and 1.0 µg LPS/mL concentrations did not have a cytotoxic effect on the cells, but 
the greater concentrations may have because they produced significantly lower numbers 
of viable cells after 48 hours of incubation.  Because the decrease in the growth (as 
compared to the growth of the cells with 0, 0.1 and 1.0 µg LPS/mL) in 5, 10, 50 and 100 
µg LPS/mL occurred after 48 hours, the decrease might by due to a lethal build-up of 
products released by the cells in response to the LPS challenge.    
 Although no nitric oxide was detected after 0 or 12 hours of challenge by either 
strain, it was detected after 24, 48 and 72 hours of LPS challenge.  This fact could be due 
to either measurement techniques, or because there were not enough cells to produce 
enough measurable nitric oxide at the lower time points.  It also could have just taken the 
cells that amount of time to produce nitric oxide in response to the LPS challenge.  
 The LPS challenge with 0.1, 1.0, 5, and 10 µg LPS/mL of E. Coli 055:B5 
resulted in a greater amount of nitric oxide than with 0 µg LPS/mL media, which is 
desirable since the 0 µg LPS/mL media did not have any LPS to induce the formation of 
nitric oxide.  These same concentrations also produced more nitric oxide than 100 µg 
LPS/mL media, which did not produce significantly more nitric oxide than the control.  
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This was also seen in the cells stimulated with LPS from the E. Coli 0111:B4 strain, the 
cells with 100 µg LPS/mL produced less nitric oxide than those with 0.1 and 1.0 µg 
LPS/mL.  This may be linked back to the fact that less cells grew in 100 µg LPS/mL 
media possibly due to the cytotoxic effects of this level of LPS challenge.  Because there 
were fewer cells to produce the nitric oxide, less nitric oxide was produced.  The cells 
stimulated with 0.1 and 1.0 µg LPS/mL media produced the most nitric oxide, which 
helped to determine that those should be the levels of LPS challenge for the subsequent 
experiments.   
 The E. Coli 0111:B4 strain did not show any differences in nitric oxide 
production until after 48 hours of stimulation, while the cells with LPS from E. Coli 
055:B5 produced more nitric oxide after 24 hours as compared to zero and 12 hours.    
Because there were more detectable differences after 24 hours of stimulation with the E. 
Coli 055:B5 strain, it was determined this strain should be used for the subsequent 
experiments. 
 
Determination of the Optimal Combination of Vitamin E and Zinc 
 This experiment was done to determine the optimal combination of vitamin E and 
zinc supplementation to use in the subsequent LPS experiments.  In this experiment, all 
the possible combinations of four different levels of vitamin E (0, 25, 50 and 100 µM) 
and four different levels of zinc (0, 10, 50, and 100 µM) were used.  There were no 
significant differences after 24 hours of growth for any of the supplementation 
concentrations.  However, there were differences after 48 hours suggesting that the 
effects of supplementation on macrophage growth took more time to develop.   After 48 
hours of growth, the cells in the 0 µM zinc and 50 µM vitamin E had a greater amount of 
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growth than the cells in the 0 µM zinc with 0 µM and 100 µM vitamin E.  The cells with 
the 50 µM zinc and 0 µM vitamin E also had a greater amount of growth than the cells 
with 50 µM zinc with 25 µM and 50 µM vitamin E.  Therefore, it was determined that for 
subsequent experiments, the levels of 50 µM zinc and 50 µM vitamin E should be used 
since both of these levels had been shown to have a positive effect on the growth of the 
macrophages.        
Of the vitamin E concentrations used in the present study (0-50 µM), the 
concentrations 50 µM would be considered pharmacological levels since the average 
intake from food according to the NHANES III, was 17.44 µmol per day, and the average 
intake from both supplements and diet was 59.75 µmol per day (Centers for Disease 
Control and Prevention 1988-1994); however, since the normal physiological serum 
concentrations ranges from 12-42 µmol/L, this dose is much greater than the 
physiological concentration.  The concentrations used were well below the upper intake 
level that ranges from 2325 µmol/day (for adults) to 465 µmol/day (for 1-3 year-olds) 
though (Institute of Medicine, 2000) 
  The highest zinc supplemented (50 µM) media used in this experiment contained 
64.526 µmol/L zinc (zinc supplementation combined with levels found in the medium 
and FBS).  This was well above the normal physiological concentrations of 10.6 to 22.78 
µmol/L (Faber et al., 2004), and greater than the pharmacological serum concentration 
seen by Estefan et al. (1998) after subjects were given an acute supplementation of 165 
mg of zinc.  
 
Determination of the Influence of Vitamin E and Zinc on Mouse Macrophage  
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Response to a Lipopolysaccharide Challenge 
   
After 24 hours of growth no significant differences in O. D. (i.e. growth) were 
seen among the various treatment groups.  After 48 hours of growth, a variety of 
differences were seen, mostly due to a decreased growth with the 10 µg indomethacin.  
All of the treatments at a LPS challenge of 0.1 µg LPS/mL media had a greater amount of 
growth after 48 hours than the 10 µg indomethacin media; however, no effects on growth 
were seen with the 5 µg indomethacin media.  Seng et al. (1990) showed that in adjuvant 
arthritic rats treated with indomethacin (1 or 2 mg/kg twice daily) proliferation of B 
lymphocytes was suppressed when stimulated with LPS; in the present study, this same 
effect may be being seen in the macrophages in response to the higher concentration (10 
µg) of the indomethacin.   
The amount of growth was also lower in the cells in the 10 µg indomethacin 
media at the LPS concentration of 1.0 µg LPS/mL media as compared to the 0 µM 
zinc/50 µM vitamin E media, revealing that either the 10 µg indomethacin treatment had 
a negative effect or the vitamin E supplementation treatment had a positive effect on 
macrophage growth.  Also at this same LPS concentration, the 0 µM zinc/50 µM vitamin 
E media and 0 µM zinc/0 µM vitamin E media had a greater amount of growth than the 
cells in the 50 µM zinc/0 µM vitamin E media, which suggests this level of zinc 
supplementation without vitamin E did not have a protective effect on cell proliferation in 
response to the higher LPS challenge.  The 5 µg indomethacin treatment had the same 
effects on growth as the vitamin E and zinc supplementations, however, the 10 µg 
indomethacin treatment caused a lesser amount of growth than all the treatments at 24 
hours, and than 0 µM zinc/50 µM vitamin E at 48 hours.  This could indicate that the 
 80
anti-inflammatory action of the zinc and vitamin E treatments is not the same as the anti-
inflammatory action of indomethacin; indomethacin may be acting to decrease 
macrophages which release inflammatory mediators, and zinc and vitamin E acting to 
decrease the mediators released.   
Increases in nitric oxide and many cytokines produced by macrophages have been 
linked to inflammatory diseases, such as atherosclerosis (Wu et al., 2001), rheumatoid 
arthritis (Simkin 1976), septic shock (Glauser et al., 1991), and graft-versus-host disease 
(Langrehr et al., 1992).  Because vitamin E and zinc supplementation have separately 
been shown to decrease the production of nitric oxide and many of inflammatory 
cytokines (Prasad et al., 2004; Abou-Mohamed et al., 1998; Wu et al., 2001; Meydani et 
al., 2002; Wu D et al, 1998; Han et al., 2000), the present study evaluated the possible 
synergistic effect supplementation with these two nutrients would have.  
 Abou-Mohamed et al. (1998) found that zinc supplementation would decrease the 
amount of nitric oxide produced in response to a LPS challenge, and Wu D et al. (1998) 
reported the same findings for vitamin E supplementation.  In the present study it was 
also observed that cells in the 0 µM zinc/50 µM vitamin E media combination at a LPS 
challenge of 0.1 µg LPS/mL media produced less nitric oxide than cells in the 0 µM 
vitamin E.  This suggests that the 0 µM zinc/50 µM vitamin E media combination had a 
beneficial effect in decreasing the amount of nitric oxide produced.    
The combination of 50 µM zinc/50 µM vitamin E produced less nitric oxide than 
the 0 µM zinc/ethanol control (0 µM vitamin E) combination at the LPS concentration of 
0.1 µg LPS/mL media.  Because the maximal combination of vitamin E and zinc did 
lower the amount of nitric oxide produced compared to the 0 µM zinc/ethanol control (0 
 81
µM vitamin E), this could suggest a beneficial effect of the use of both zinc and vitamin 
E supplementation.  However, the maximal combination of zinc and vitamin E did not 
produce a significantly lower amount of nitric oxide than the 0 µM zinc/50 µM vitamin E 
combination, so the effect could be due to just the vitamin E supplementation.  The 
present study was also unable to show a beneficial effect of zinc supplementation alone 
on decreased amounts of nitric oxide produced, as has been previously shown elsewhere 
(Abou-Mohamed et al., 1998) possibly due to different measurement techniques or zinc 
supplementation techniques.   
Prasad et al. (2004) indicated that zinc supplementation could reduce the amount 
of tumor necrosis factor-α (TNF-α) produced in response to a LPS challenge.  These 
results were not reproduced in the present study; there were no significant differences 
among any of the zinc treatments used.  Han et al. (2000) had shown that vitamin E 
supplementation could decrease the amount of TNF-α produced in vivo, which we were 
also unable to reproduce in vitro.  More TNF-α was produced by the cells that were 
stimulated with LPS, as is expected, but no differences were found in any of the media 
treatments possibly due to small sample size. 
Another inflammatory mediator, PGE2, has been indicated to be decreased by 
vitamin E supplementation (Wu D et al., 1998).  The present study did not demonstrate 
these results possibly due to small sample size or measurement techniques, but did find 
that the cells in the 0 µM zinc/50 µM vitamin E media produced more PGE2 than those in 
the 5 µg and 10 µg indomethacin at the 1.0 µg LPS/mL media concentration, suggesting 
that the indomethacin did lower the amount of PGE2 produced, which was expected.  
Indomethacin acts as an anti-inflammatory medication by inhibiting COX-1 and COX-2 
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production (Futaki et al., 1994), which causes the decreased formation of PGE2.  It was 
also revealed that the cells grown in the 0 µM zinc/50 µM vitamin E media that were 
stimulated with 1.0 µg LPS/mL media produced more PGE2 than the cells grown in the 
same media that were not stimulated with LPS, suggesting that the LPS challenge was 
able to cause the cells to produce more PGE2.   
Interleukin-10 (IL-10) is an anti-inflammatory agent causing the suppression of 
the production of inflammatory mediators such as TNF-α, IL-1β and IL-6 by monocytes 
(De Waal Malefyt et al., 1991).  An increase in IL-10 would have a positive effect in 
keeping the inflammatory response in check.  The present study revealed no significant 
differences in IL-10 produced among the vitamin E and zinc supplementation treatments, 
but did reveal the 5 and 10 µg indomethacin treatments produced more IL-10 than all of 
the medias except for the control (0 µM zinc/0 µM vitamin E supplemented media).  This 
was also indicated by Rhind et al. (2002) who found IL-10 production to be increased by 
indomethacin following an intense exercise session, whereas Andreone et al. (2003) 
found indomethacin to decrease IL-10 production.  Because IL-10 is an anti-
inflammatory mediator, this decrease is not desired.   
The present study demonstrated less nitric oxide was produced by the cells 
receiving 50 µM of both vitamin E and zinc, which suggests a beneficial effect of the 
supplementation with both nutrients in reducing the inflammatory response; however, 
vitamin E supplementation alone also revealed this effect.  The addition of 5 and 10 µg 
indomethacin was able to cause an increase in IL-10 produced, as well as a decrease in 
PGE2, in response to a LPS challenge revealing its beneficial effects on the inflammatory 
immune response.  If a greater sample size were used or a different model, such as an in 
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vivo model, a relation among vitamin E and zinc supplementation could have possibly 
been shown, but with the sample sizes and the in vitro model used, it was unable to be 
shown that a vitamin E and zinc supplementation synergistic relationship decreased the 
inflammatory response mediators measured.  Also, the cells were supplemented with zinc 
and vitamin E concentrations for 24 hours before receiving the LPS challenge, if the LPS 
challenge were given at the same time as the zinc and vitamin E treatment, a greater 
amount of differences may have been observed.  Cellular uptake studies with zinc have 
shown there are two phases to zinc uptake, rapid and slow (Stacey & Klaasen, 1981; Ong 
et at., 1995), since the LPS was added 24 hours after the media treatments, the rapid 
uptake had already occurred as well as quite a bit of the slow uptake.  A considerable 
amount of vitamin E uptake had occurred as well, even though Saito et al. (2004) showed 





SUMMARY, CONCLUSIONS, AND LIMITATIONS 
 
 The first experiments were conducted to determine the appropriate concentrations 
of vitamin E, zinc, lipopolysaccharide and cell density to use in the final experiment 
testing the main hypothesis.  The main hypothesis of this study was that vitamin E and 
zinc supplementation would act synergistically to lower inflammatory response cytokines 
and nitric oxide more than vitamin E or zinc supplementation alone.  The first five 
experiments were successful in determining which levels should be used.  
For these experiments, the most appropriate cell density was 1 x 10 4 cells/per 
well in a 96 well plate.  It was also determined that the most beneficial effects in growth 
were due to levels of 50 µM vitamin E supplementation and 50 µM or less of zinc 
supplementation.  The optimal results based on nitric oxide production and number of 
viable macrophages for macrophages challenged with E. Coli 055:B5 or E. Coli 0111:B4 
in this study were from those challenged with E. Coli 055:B5 at levels of 0.1 and 1.0 µg 
LPS/mL media.  The data from the first five experiments helped to setup the main 
experiment.   
It is well documented that increases in inflammatory cytokines and nitric oxide 
are involved in several inflammatory diseases, such as rheumatoid arthritis (Simkin, 
1976), atherosclerosis (Wu et al., 2001), and many others.  Prostaglandin-E2, TNF-α, and 
nitric oxide have all been implicated in these diseases.   
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The present study indicates that vitamin E supplementation did in fact lower the 
amount of nitric oxide produced in response to a LPS challenge, as was shown by Wu D 
et al (1998), and that the supplementation of both vitamin E and zinc lowered nitric oxide 
but it did not lower it more than vitamin E alone.  Therefore, whether or not a synergistic 
effect existed that decreased nitric oxide more than just supplementation with E alone 
was unable to be shown.   
The present study also did not suggest a decrease in TNF-α due to vitamin E or 
zinc supplementation, or supplementation with both.  The same was true for PGE2 and 
IL-10 (no increase).  Since other studies have shown differences in these cytokines due to 
vitamin E supplementation or zinc supplementation, the sample sizes in the present were 
possibly too small to reveal these same results, or the model used was not satisfactory to 
reveal these same results.     
The macrophages treated with the 5 and 10 µg indomethacin produced more IL-
10, an inflammatory response inhibitor, than the macrophages in the other mediums, 
indicating this medication’s anti-inflammatory properties.  These same macrophages 
were also able to lower the amount of PGE2 produced, which would also suggest 
indomethacin’s anti-inflammatory properties.   
Since no significant differences were found in concentrations of pro-inflammatory 
mediators (TNF-α  and PGE2) in the different treatments, the hypothesis that the 
treatment with both vitamin E and zinc would reduce these mediators to a greater extent 
than vitamin E or zinc supplementation has not been proven.  It was shown that the 
macrophages in the vitamin E and zinc supplemented media did produce less nitric oxide 
than the macrophages in the zinc supplemented and control treatments, but it was not 
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shown that they produced less than the macrophages in the vitamin E supplemented 
media; therefore, the hypothesis that supplementation with both vitamin E and zinc 
would decrease nitric oxide more than supplementation with zinc or vitamin E alone was 
also not proven.  It was also not shown that supplementation with both vitamin E and 
zinc increased IL-10 production more than vitamin E or zinc supplementation alone.      
The present study did not indicate a synergistic effect of vitamin E and zinc 
supplementation on the response of mouse macrophages to a LPS challenge.  However, 
future studies with larger sample sizes are needed to prove whether or not vitamin E and 
zinc supplementation can act together to further decrease the amount of nitric oxide and 
inflammatory cytokines. Other inflammatory mediators, such as IL-1, IL-6, and IL-12, 
should also be measured in order to determine if there is a synergistic effect of vitamin E 
and zinc supplementation.  Additional models should be used also to determine the 
effects of these supplementations on the whole immune system, not just the part this 
study considered.   
Limitations 
The present study had several limitations since it was an in vitro study.  In in vitro 
studies, only an isolated cell type is studied, in this case the macrophage; however, in 
vitro studies helps researchers to better understand the action of certain cells, and help to 
determine if an in vivo study would be warranted.  The macrophage is just one of many 
immune cells in the body; therefore, even though the present study did not indicate a 
synergistic effect of vitamin E and zinc, it does not mean they do not have a beneficial 
synergistic effect on the immune system’s inflammatory response.  Also, because zinc 
has been shown to affect the absorption of vitamin E in the body (Hatfield et al., 2002), 
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this model is unable to determine just how much of the supplementation would be 
absorbed by the body or how much would actually be absorbed by the macrophage.  
Other than the model, the types of cytokines measured also limited this study; if more 
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